UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2024

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                 to                 

 

Commission File Number: 001-36616

  

 

 

LogicMark, Inc.

(Exact name of registrant as specified in its charter)

   

Nevada   46-0678374
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

2801 Diode Lane
Louisville, KY 40299

(Address of principal executive offices) (Zip Code)

 

(502) 442-7911
(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
Common Stock, par value $0.0001 per share   LGMK   Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 

As of August 12, 2024, there were 6,065,383 shares of common stock, par value $0.0001 per share, of the registrant issued and outstanding.

 

 

 

 

 

 

LogicMark, Inc.

Form 10-Q

 

Table of Contents

June 30, 2024

 

    Page
Part I FINANCIAL INFORMATION 1
     
Item 1 Condensed Financial Statements (Unaudited); 1
     
  Condensed Balance Sheets - June 30, 2024 and December 31, 2023 1
     
  Condensed Statements of Operations – Three and Six Months Ended June 30, 2024 and 2023 2
     
  Condensed Statements of Changes in Stockholders’ Equity - Three and Six Months Ended June 30, 2024 and 2023 3
     
  Condensed Statements of Cash Flows for the Six Months Ended June 30, 2024 and 2023 5
     
  Notes to Condensed Financial Statements 6
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 18
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 22
     
Item 4. Controls and Procedures 22
     
Part II. OTHER INFORMATION 23
     
Item 1. Legal Proceedings 23
     
Item 1A. Risk Factors 23
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23
     
Item 3. Defaults upon Senior Securities 23
     
Item 4. Mine Safety Disclosures 23
     
Item 5. Other Information 23
     
Item 6. Exhibits 23
     
  Signatures 24

 

i

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Condensed Financial Statements (Unaudited)

 

LogicMark, Inc.

CONDENSED BALANCE SHEETS

(Unaudited)

 

   June 30,   December 31, 
   2024   2023 
Assets        
Current Assets        
Cash and cash equivalents  $2,959,815   $6,398,164 
Accounts receivable, net   11,918    13,647 
Inventory   678,537    1,177,456 
Prepaid expenses and other current assets   773,894    460,177 
Total Current Assets   4,424,164    8,049,444 
           
Property and equipment, net   161,501    203,333 
Right-of-use assets, net   82,298    113,761 
Product development costs, net of amortization of $216,151 and $68,801, respectively   1,368,120    1,269,021 
Software development costs, net of amortization of $161,775 and $23,354, respectively   1,637,875    1,299,901 
Goodwill   3,143,662    3,143,662 
Other intangible assets, net of amortization of $6,047,407 and $5,666,509, respectively   2,557,160    2,938,058 
Total Assets  $13,374,780   $17,017,180 
           
Liabilities, Series C Redeemable Preferred Stock and Stockholders’ Equity          
           
Current Liabilities          
Accounts payable  $796,815   $901,624 
Accrued expenses   767,717    1,151,198 
Deferred revenue   25,069    
-
 
Total Current Liabilities   1,589,601    2,052,822 
Other long-term liabilities   13,382    51,842 
Total Liabilities   1,602,983    2,104,664 
           
Commitments and Contingencies (Note 8)   
 
    
 
 
           
Series C Redeemable Preferred Stock          
Series C redeemable preferred stock, par value $0.0001 per share: 2,000 shares designated; 10 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively   1,807,300    1,807,300 
           
Stockholders’ Equity          
Preferred stock, par value $0.0001 per share: 10,000,000 shares authorized   
 
    
 
 
Series F preferred stock, par value $0.0001 per share:  1,333,333 shares designated; 106,333 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively, aggregate liquidation preference of $319,000 as of June 30, 2024 and as of December 31, 2023, respectively   319,000    319,000 
Common stock, par value $0.0001 per share: 100,000,000 shares authorized; 2,193,587 and 2,150,412 issued and outstanding as of June 30, 2024 and December 31, 2023, respectively   220    216 
Additional paid-in capital   113,589,568    112,946,891 
Accumulated deficit   (103,944,291)   (100,160,891)
           
Total Stockholders’ Equity   9,964,497    13,105,216 
           
Total Liabilities, Series C Redeemable Preferred Stock and Stockholders’ Equity  $13,374,780   $17,017,180 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

1

 

 

LogicMark, Inc.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

 

   For the Three Months Ended
June 30,
   For the Six Months Ended
June 30,
 
   2024   2023   2024   2023 
Revenues  $2,336,268   $2,326,995   $4,947,351   $5,136,713 
Costs of goods sold   781,318    727,276    1,625,183    1,674,445 
Gross Profit   1,554,950    1,599,719    3,322,168    3,462,268 
                     
Operating Expenses                    
Direct operating cost   320,660    312,426    651,580    575,228 
Advertising costs   135,220    85,277    287,433    133,393 
Selling and marketing   605,493    517,931    1,193,031    983,466 
Research and development   133,556    250,266    307,458    564,154 
General and administrative   1,982,997    2,443,860    3,881,960    4,857,619 
Other expense   69,932    50,646    153,758    78,964 
Depreciation and amortization   377,974    215,703    723,525    431,701 
                     
Total Operating Expenses   3,625,832    3,876,109    7,198,745    7,624,525 
                     
Operating Loss   (2,070,882)   (2,276,390)   (3,876,577)   (4,162,257)
                     
Other Income                    
Interest income   32,025    8,510    93,177    60,938 
Total Other Income   32,025    8,510    93,177    60,938 
                     
Loss before Income Taxes   (2,038,857)   (2,267,880)   (3,783,400)    (4,101,319)
Income tax expense   
-
    
-
    
-
    
-
 
Net Loss   (2,038,857)   (2,267,880)   (3,783,400)   (4,101,319)
Preferred stock dividends   (75,000)   (75,000)   (150,000)   (150,000)
Net Loss Attributable to Common Stockholders  $(2,113,857)  $(2,342,880)  $(3,933,400)  $(4,251,319)
                     
Net Loss Attributable to Common Stockholders Per Share - Basic and Diluted
  $(0.96)  $(1.83)  $(1.81)  $(3.73)
                     
Weighted Average Number of Common Shares Outstanding - Basic and Diluted
   2,190,716    1,282,794    2,170,564    1,139,437 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

2

 

 

LogicMark, Inc.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

 

   Three Months Ended June 30, 2024 
                   Additional         
   Preferred Stock   Common Stock   Paid-in   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
Balance - March 31, 2024   106,333   $319,000    2,150,412   $216   $113,257,840   $(101,905,434)  $11,671,622 
                                    
Stock based compensation expense   -    -    -    -    408,512    -    408,512 
                                    
Shares issued as stock compensation   -    -    46,200    4    2,884    -    2,888 
                                    
Common stock withheld to pay taxes   -    
-
    (3,025)   
-
    (4,235)   
-
    (4,235)
                                    
Fees incurred in connection with equity offerings   -    -    -    -    (433)   -    (433)
                                    
Series C Preferred stock dividends   -    -    -    -    (75,000)   -    (75,000)
                                    
Net loss   -    
-
    -    
-
         (2,038,857)   (2,038,857)
                                    
Balance - June 30, 2024   106,333   $319,000    2,193,587   $220   $113,589,568   $(103,944,291)  $9,964,497 

  

   Six Months Ended June 30, 2024 
                   Additional         
   Preferred Stock   Common Stock   Paid-in   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
Balance - January 1, 2024   106,333   $319,000    2,150,412   $216   $112,946,891   $(100,160,891)  $13,105,216 
                                    
Stock based compensation expense   -    -    -    -    826,198    -    826,198 
                                    
Shares issued as stock compensation   -    -    46,200    4    2,884    -    2,888 
                                    
Common stock withheld to pay taxes   -    
-
    (3,025)   
-
    (4,235)   
-
    (4,235)
                                    
Fees incurred in connection with equity offerings   -    -    -    -    (32,170)   -    (32,170)
                                    
Series C Preferred stock dividends   -    -    -    -    (150,000)   -    (150,000)
                                    
Net loss   -    -    -    -    -    (3,783,400)   (3,783,400)
                                    
Balance - June 30, 2024   106,333   $319,000    2,193,587   $220   $113,589,568   $(103,944,291)  $9,964,497 

 

3

 

 

LogicMark, Inc.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

 

   Three Months Ended June 30, 2023 
                   Additional         
   Preferred Stock   Common Stock   Paid-in   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
Balance - April 1, 2023  106,333   $319,000   1,220,308   $123   $111,079,795   $(87,443,721)  $23,955,197 
                                    
Stock based compensation expense   -    -    -    -    365,458    -    365,458 
                                    
Fees incurred in connection with equity offerings   -    -    -    -    (10,772)   -    (10,772)
                                    
Fractional shares issued in the 1-for-20 stock split   -    
-
    40,228    4    (4)   
-
    
-
 
                                    
Warrants exercised for common stock   -    
-
    64,481    6    162,488    
-
    162,494 
                                    
Series C Preferred stock dividends   -    -    -    -    (75,000)   -    (75,000)
                                    
Net loss   -    -    -    -    -    (2,267,880)   (2,267,880)
                                    
Balance - June 30, 2023   106,333   $319,000    1,325,017   $133   $111,521,965   $(89,711,601)  $22,129,497 

 

   Six Months Ended June 30, 2023 
                   Additional         
   Preferred Stock   Common Stock   Paid-in   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
Balance - January 1, 2023  173,333   $520,000   480,447   $48   $106,070,253   $(85,610,282)  $20,980,019 
                                    
Stock based compensation expense   -    -    -    -    792,300    -    792,300 
                                    
Shares issued as stock based compensation   -    -    5,000    1    2,202    -    2,203 
                                    
Sale of common stock, pre-funded warrants and warrants pursuant to a registration statement on Form S-1   -    
-
    701,250    70    5,211,358    
-
    5,211,428 
                                    
Fees incurred in connection with equity offerings   -    -    -    -    (816,017)   -    (816,017)
                                    
Fractional shares issued in the 1-for-20 stock split   -    
-
    40,228    4    (4)   
-
    
-
 
                                    
Warrants exercised for common stock   -    
-
    64,481    6    162,488    
-
    162,494 
                                    
Series F Preferred stock converted to common stock   (67,000)   (201,000)   27,089    3    200,997    
-
    
-
 
                                    
Common stock issued as Series F Preferred stock dividends   -    
-
    6,522    1    48,388    
-
    48,389 
                                    
Series C Preferred stock dividends   -    -    -    -    (150,000)   -    (150,000)
                                    
Net loss   -    -    -    -    -    (4,101,319)   (4,101,319)
                                    
Balance - June 30, 2023   106,333   $319,000    1,325,017   $133   $111,521,965   $(89,711,601)  $22,129,497 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4

 

 

LogicMark, Inc.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   For the Six Months Ended
June 30,
 
   2024   2023 
Cash Flows from Operating Activities        
Net loss  $(3,783,400)  $(4,101,319)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation   56,859    50,803 
Stock based compensation   829,086    794,503 
Amortization of intangible assets   380,898    380,898 
Amortization of product development costs   147,350    
-
 
Amortization of software development costs   138,421    
-
 
Loss on disposal of fixed assets   1,654    
-
 
Deferred Revenue   25,069    
-
 
Changes in operating assets and liabilities:          
Accounts receivable   1,729    386,186 
Inventory   498,919    757,992 
Prepaid expenses and other current assets   (94,097)   (251,173)
Accounts payable   (281,725)   (372,865)
Accrued expenses   (539,366)   (840,937)
Net Cash Used in Operating Activities   (2,618,603)   (3,195,912)
           
Cash flows from Investing Activities          
Purchase of equipment and website development   (16,678)   (48,697)
Product development costs   (165,416)   (400,630)
Software development costs   (384,739)   (90,050)
Net Cash Used in Investing Activities   (566,833)   (539,377)
           
Cash flows from Financing Activities          
Proceeds from the sale of common stock and warrants   
-
    5,211,428 
Fees paid in connection with equity offerings   (98,678)   (816,017)
Common stock withheld to pay taxes   (4,235)   
-
 
Warrants exercised for common stock   
-
    162,494 
Series C redeemable preferred stock dividends   (150,000)   (150,000)
Net Cash (Used in) Provided by Financing Activities   (252,913)   4,407,905 
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash   (3,438,349)   672,616 
Cash, Cash Equivalents and Restricted Cash - Beginning of Period   6,398,164    7,037,102 
Cash, Cash Equivalents and Restricted Cash - End of Period  $2,959,815   $7,709,718 
           
Supplemental Disclosures of Cash Flow Information:          
Non-cash investing and financing activities:          
Conversion of Series F preferred stock to common stock  $
-
   $201,000 
Common stock issued to settle Series F preferred stock dividends   
-
    48,389 
Fees in connection with deferred offering costs included in accounts payable and accrued expenses   153,113    
-
 
Product development costs included in accounts payable and accrued expenses   81,033    130,027 
Software development costs included in accounts payable and accrued expenses   91,656    16,478 

  

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

5

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 - ORGANIZATION AND PRINCIPAL BUSINESS ACTIVITIES

 

LogicMark, Inc. (“LogicMark” or the “Company”) was incorporated in the State of Delaware on February 8, 2012 and was reincorporated in the State of Nevada on June 1, 2023. LogicMark operates its business in one segment and provides personal emergency response systems (“PERS”), health communications devices, and Internet of Things technology that creates a connected care platform. The Company’s devices give people the ability to receive care at home and confidence to age independently. LogicMark revolutionized the PERS industry by incorporating two-way voice communication technology directly in the medical alert pendant and providing life-saving technology at a price point everyday consumers could afford. The PERS technologies as well as other personal safety devices are sold direct-to-consumer through the Company’s eCommerce website and Amazon.com, through dealers and distributors, as well as directly to the United States Veterans Health Administration (“VHA”).

 

NOTE 2 - LIQUIDITY AND MANAGEMENT PLANS

 

The Company generated an operating loss of $3.9 million and a net loss of $3.8 million for the six months ended June 30, 2024. As of June 30, 2024, the Company had cash and cash equivalents of $3.0 million. As of June 30, 2024, the Company had working capital of $2.8 million and accumulated deficit of $103.9 million, compared to working capital and accumulated deficit as of December 31, 2023 of $6.0 million and $100.2 million, respectively.

 

Given the Company’s cash position as of June 30, 2024, and its projected cash flow from operations, the Company believes that it will have sufficient capital to sustain operations for a period of one year following the date of this filing. The Company may also raise funds through equity or debt offerings to accelerate the execution of its long-term strategic plan to develop and commercialize its core products and to fulfill its product development efforts. As further described in Note 9, Subsequent Event, on August 5, 2024, the Company closed a firm commitment public offering that resulted in gross proceeds to the Company of approximately $4.5 million.

 

NOTE 3 - BASIS OF PRESENTATION

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. In the opinion of management, the information herein reflects all adjustments, consisting only of normal recurring adjustments, except as otherwise noted, considered necessary for a fair statement of results of operations, financial position, stockholders’ equity, and cash flows. The results for the interim periods presented are not necessarily indicative of the results expected for any future period. The following information should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 which was filed with the SEC on April 16, 2024.

 

6

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

USE OF ESTIMATES IN THE CONDENSED FINANCIAL STATEMENTS

 

U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s management evaluates these significant estimates and assumptions, including those related to the fair value of acquired assets and liabilities, stock based compensation, income taxes, allowance for doubtful accounts, long-lived assets, and inventories, and other matters that affect the condensed financial statements and disclosures. Actual results could differ from those estimates.

 

CASH AND CASH EQUIVALENTS

 

The Company considers all highly liquid securities with an original maturity date of three months or less when purchased to be cash equivalents. Due to their short-term nature, cash equivalents are carried at cost, which approximates fair value. The Company had cash equivalents of $1.7 million and $4.7 million as of June 30, 2024 and December 31, 2023, respectively.

 

RESTRICTED CASH

 

Restricted cash includes amounts held as collateral for company credit cards. During the year ended December 31, 2023, the Company closed the company credit card and changed to a vendor that did not require cash collateral. As of June 30, 2024 and December 31, 2023, the Company did not have restricted cash.

 

CONCENTRATIONS OF CREDIT RISK

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains its cash and cash equivalents balances in large well-established financial institutions located in the United States. At times, the Company’s cash balances may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits.

 

7

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

REVENUE RECOGNITION

 

The Company’s revenues consist of product sales to either end customers, to distributors or direct bulk sales to the VHA. The Company’s revenues are derived from contracts with customers, which are in most cases customer purchase orders. For each contract, the promise to transfer the title of the products, each of which is individually distinct, is considered to be the identified performance obligation. As part of the consideration promised in each contract, the Company evaluates the customer’s credit risk. Our contracts do not have any financing components, as payments are mostly prepaid, or in limited cases, due net 30 days after the invoice date. The majority of prepaid contracts are with the VHA, which consists of the majority of the Company’s revenues. The Company’s products are almost always sold at fixed prices. In determining the transaction price, we evaluate whether the price is subject to any refunds, due to product returns or adjustments due to volume discounts, rebates, or price concessions to determine the net consideration we expect to be entitled to. The Company’s sales are recognized at a point-in-time under the core principle of recognizing revenue when title transfers to the customer, which generally occurs when the Company ships or delivers the product from its fulfillment center to our customers, when our customer accepts and has legal title of the goods, and the Company has a present right to payment for such goods. Based on the respective contract terms, most of our contract revenues are recognized either (i) upon shipment based on free on board (“FOB”) shipping point, or (ii) when the product arrives at its destination.

 

During the year ended December 31, 2023, the Company released new product and service offerings by leasing hardware coupled with monthly subscription services. The Company accounts for the revenue from its lease contracts by utilizing the single component accounting policy. This policy requires the Company to account for, by class of underlying asset, the lease component and non-lease component(s) associated with each lease as a single component if two criteria are met: (1) the timing and pattern of the lease component and the non-lease component are the same and (2) the lease component would be classified as an operating lease, if accounted for separately. The Company has determined that its leased hardware meets the criteria to be operating leases and has the same timing and pattern of transfer as its monthly subscription services. The Company has elected the lessor practical expedient within ASC 842, Leases (“ASC 842”) and recognizes, measures, presents, and discloses the revenue for the new offering based upon the predominant component, either the lease or non-lease component. The Company recognizes revenue under ASC 606, Revenue Recognition from Contracts with Customers (“ASC 606”) for its leased product for which it has estimated that the non-lease components of the new offering is the predominant component of the contract. For the three and six months ended June 30, 2024, the Company’s sales recognized over time were immaterial. For the three and six months ended June 30, 2023, none of the Company’s sales were recognized over time.

 

SALES TO DISTRIBUTORS AND RESELLERS

 

The Company maintains a reserve for unprocessed and estimated future price adjustments, claims and returns as a refund liability. The reserve is recorded as a reduction to revenue in the same period that the related revenue is recorded and is calculated based on an analysis of historical claims and returns over a period of time to appropriately account for current pricing and business trends. Similarly, sales returns and allowances are recorded based on historical return rates, as a reduction to revenue with a corresponding reduction to cost of goods sold for the estimated cost of inventory that is expected to be returned. These reserves were not material as of June 30, 2024 and December 31, 2023.

 

SHIPPING AND HANDLING

 

Amounts billed to customers for shipping and handling are included in revenues. The related freight charges incurred by the Company are included in cost of goods sold and were $0.1 million for the three and six months ended June 30, 2024, respectively, and $0.1 million and $0.2 million for the three and six months ended June 30, 2023.

 

8

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

ACCOUNTS RECEIVABLE - NET

 

For the three and six months ended June 30, 2024 and 2023, the Company’s revenues were primarily the result of shipments to VHA hospitals and clinics, which are made in most cases on a prepaid basis. The Company also sells its products to distributors and resellers, typically providing customers with modest trade credit terms. Sales made to distributors and resellers are done with limited rights of return and are subject to the normal warranties offered to the ultimate consumer for product defects.

 

Accounts receivable is stated at net realizable value. The Company regularly reviews accounts receivable balances and adjusts the accounts receivable allowance for credit losses, as necessary whenever events or circumstances indicate the carrying value may not be recoverable. As of June 30, 2024 and December 31, 2023, the allowance for credit losses was immaterial.

 

INVENTORY

 

The Company measures inventory at the lower of cost or net realizable value, defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Cost is determined using the first-in, first-out method.

 

The Company performs regular reviews of inventory quantities on hand and evaluates the realizable value of its inventories. The Company adjusts the carrying value of the inventory as necessary for excess, obsolete, and slow-moving inventory by comparing the individual inventory parts to forecasted product demand or production requirements. As of June 30, 2024, inventory was composed of $0.7 million in finished goods on hand. As of December 31, 2023, inventory was composed of $1.2 million in finished goods on hand.

 

The Company is required to partially prepay for inventory with certain vendors. As of June 30, 2024 and December 31, 2023, $0.4 million and $0.3 million, respectively, of prepayments were made for inventory in both periods and are included in prepaid expenses and other current assets on the balance sheet.

 

LONG-LIVED ASSETS

 

Long-lived assets, such as property and equipment, and other intangible assets are evaluated for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. When indicators exist, the Company tests for the impairment of the definite-lived assets based on the undiscounted future cash flow the assets are expected to generate over their remaining useful lives, compared to the carrying value of the assets. If the carrying amount of the assets is determined not to be recoverable, a write-down to fair value is recorded. Management estimates future cash flows using assumptions about expected future operating performance. Management’s estimates of future cash flows may differ from actual cash flow due to, among other things, technological changes, economic conditions, or changes to the Company’s business operations.

 

9

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

PROPERTY AND EQUIPMENT

 

Property and equipment consisting of equipment, furniture, fixtures, website and other is stated at cost. The costs of additions and improvements are generally capitalized and expenditures for repairs and maintenance are expensed in the period incurred. When items of property and equipment are sold or retired, the related costs and accumulated depreciation are removed from the accounts and any gain or loss is included in income. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful life of the respective asset as follows:

 

Equipment  5 years
Furniture and fixtures  3 to 5 years
Website and other  3 years

 

GOODWILL

 

Goodwill is reviewed annually in the fourth quarter, or when circumstances indicate that an impairment may have occurred. The Company first performs a qualitative assessment of goodwill impairment, which considers factors such as market conditions, performance compared to forecast, business outlook and unusual events. If the qualitative assessment indicates a possible goodwill impairment, goodwill is then quantitatively tested for impairment. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative test. If a quantitative goodwill impairment test is required, the fair value is determined using a variety of assumptions including estimated future cash flows using applicable discount rates (income approach), comparisons to other similar companies (market approach), and an adjusted balance sheet approach. As of June 30, 2024, no indicators of impairment were noted.

 

OTHER INTANGIBLE ASSETS

 

The Company’s intangible assets are related to the acquisition of LogicMark LLC in 2016, the former subsidiary that was merged with and into the Company and are included in other intangible assets in the Company’s condensed balance sheets as of June 30, 2024 and December 31, 2023.

 

As of June 30, 2024, the other intangible assets are composed of patents of $1.1 million; trademarks of $0.8 million; and customer relationships of $0.7 million. As of December 31, 2023, the other intangible assets are composed of patents of $1.3 million; trademarks of $0.8 million; and customer relationships of $0.8 million. The Company amortizes these intangible assets using the straight-line method over their estimated useful lives which for the patents, trademarks and customer relationships are 11 years, 20 years, and 10 years, respectively. During the three and six months ended June 30, 2024, the Company had amortization expense of $0.2 million and $0.4 million, respectively. During the three and six months ended June 30, 2023, the Company had amortization expense of $0.2 million and $0.4 million, respectively.

 

As of June 30, 2024, total amortization expense estimated for the remainder of fiscal year 2024 was $0.4 million. Amortization expense estimated for 2025 is expected to be approximately $0.8 million, $0.6 million for 2026, $0.3 million for 2027, $0.1 million for 2028, and approximately $0.4 million thereafter.

 

STOCK BASED COMPENSATION

 

The Company accounts for stock based awards exchanged for employee services at the estimated grant date fair value of the award. The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Stock based compensation charges are amortized over the vesting period or as earned. Stock based compensation is recorded in the same component of operating expenses as if it were paid in cash.

 

NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER SHARE

 

Basic net loss attributable to common stockholders per share (“Basic net loss per share”) was computed using the weighted average number of common shares outstanding. Diluted net loss applicable to common stockholders per share (“Diluted net loss per share”) includes the effect of diluted common stock equivalents. Potentially dilutive securities from the exercise of stock options to purchase 170,470 shares of common stock and warrants to purchase 9,284,290 shares of common stock as of June 30, 2024, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. Potentially dilutive securities from the exercise of stock options to purchase 35,928 shares of common stock and warrants to purchase 1,253,985 shares of common stock as of June 30, 2023, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive.

 

10

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

RESEARCH AND DEVELOPMENT AND PRODUCT AND SOFTWARE DEVELOPMENT COSTS

 

Research and development costs are expenditures on new market development and related engineering costs. In addition to internal resources, the Company utilizes functional consulting resources, third-party software, and hardware development firms. The Company expenses all research and development costs as incurred until technological feasibility has been established for the product. Once technological feasibility is established, development costs including software and hardware design are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. For the three months ended June 30, 2024, the Company capitalized $0.2 million and $0.2 million in product development costs and software development costs, respectively. For the six months ended June 30, 2024, the Company capitalized $0.3 million and $0.5 million in product development cost and software development costs, respectively. For the three and six months ended June 30, 2023, the Company capitalized $0.3 million and $0.5 million of such product development costs, respectively, and capitalized $0.1 million of such software development costs for both periods.  Amortization of these costs was on a straight-line basis over three years and amounted to approximately $73.9 thousand and $85.1 thousand for product development and software development, respectively, for the three months ended June 30, 2024. For the six months ended June 30, 2024, amortization of these costs amounted to approximately $147.4 thousand and $138.4 thousand for product development and software development, respectively. There was no amortization of product development costs during the three and six months ended June 30, 2023. Cumulatively, as of June 30, 2023, approximately $0.6 million of capitalized product development costs arose from expenditures to a company considered to be a related party since it is controlled by the Company’s Vice-President of Engineering.

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its financial statements and disclosures. 

 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which provides an update to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-07 will have a material impact on its financial statements and disclosures. 

 

11

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 5 - ACCRUED EXPENSES

 

Accrued expenses consist of the following:

 

   June 30,   December 31, 
   2024   2023 
Salaries, payroll taxes and vacation  $170,329   $167,930 
Merchant card fees   21,500    14,983 
Professional fees   101,920    83,532 
Management incentives   203,431    503,800 
Lease liability   74,116    68,321 
Development costs   70,000    109,000 
Other   126,421    203,632 
Totals  $767,717   $1,151,198 

 

NOTE 6 - STOCKHOLDERS’ EQUITY AND REDEEMABLE PREFERRED STOCK

 

November 2023 Warrant Inducement Transactions

 

On November 21, 2023, the Company entered into inducement agreements (together, the “Inducement Agreements”) with certain of its warrant holders, pursuant to which the Company induced such warrant holders to exercise for cash their common stock purchase warrants issued pursuant to firm commitment public offerings by the Company that closed on September 15, 2021 (the “Existing September 2021 Warrants”) and January 25, 2023 (the “Existing January 2023 Warrants” and together with the Existing September 2021 Warrants, the “Existing Warrants”) to purchase up to approximately 909,059 shares of Common Stock, at a lower exercise price of (x) $2.00 per share for the Existing September 2021 Warrants and (y) $2.00 per one and one-half share for the Existing January 2023 Warrants, during the period from the date of the Inducement Agreements until December 20, 2023 (the “Inducement Deadline”). In consideration for the warrant holders’ agreement to exercise the Existing Warrants in accordance with the Inducement Agreements, the Company agreed to issue such warrant holders the Warrants as follows: (A) Series A Common Stock purchase warrants (the “Series A Warrants”) to purchase up to a number of shares of Common Stock equal to 200% of the number of shares of Common Stock issued upon exercise of the Existing September 2021 Warrants (up to 80,732 shares) (the “Series A Warrant Shares”), at an exercise price of $2.00 per Series A Warrant Share; and (B) Series B Common Stock purchase warrants (the “Series B Warrants”) to purchase up to a number of shares of Common Stock equal to 200% of the number of shares of Common Stock issued upon exercise of the Existing January 2023 Warrants (up to 1,382,058 shares) (the “Series B Warrant Shares”), at an exercise price of $2.00 per one and one-half Series B Warrant Share. Of the Series A Warrants, 50% are immediately exercisable and expire on the Termination Date (as defined in the Existing September 2021 Warrants) and 50% are exercisable at any time on or after the Stockholder Approval Date (as defined in the Inducement Agreements), and have a term of exercise of five and a half years from the date of the initial closing of the transactions contemplated by the Inducement Agreements. Of the Series B Warrants, 50% are immediately exercisable and expire on the Termination Date (as defined in the Existing January 2023 Warrants) and 50% are exercisable at any time on or after the Stockholder Approval Date, and have a term of exercise of five and a half years from the date of the initial closing of the transactions contemplated by the Inducement Agreements. The Company used the proceeds from the exercise of the Existing Warrants for working capital purposes and other general corporate purposes. On May 22, 2024, the November 2023 Warrant Inducement was approved by stockholders at the Annual Meeting of Stockholders.

  

12

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 6 - STOCKHOLDERS’ EQUITY AND REDEEMABLE PREFERRED STOCK (CONTINUED)

 

January 2023 Offering

 

On January 25, 2023, the Company closed a firm commitment registered public offering (the “January Offering”) pursuant to which the Company issued (i) 529,250 shares of Common Stock and 10,585,000 common stock purchase warrants (exercisable for 793,875 shares of Common Stock at a purchase price of $2.52 per share), subject to certain adjustments and (ii) 3,440,000 pre-funded common stock purchase warrants that were exercised for 172,000 shares of Common Stock at a purchase price of $0.02 per share, subject to certain adjustments and 3,440,000 warrants to purchase up to an aggregate of 258,000 shares of Common Stock at a purchase price of $2.52 per share and (iii) 815,198 additional warrants to purchase up to 61,140 shares of Common Stock at a purchase price of $2.52 per share, which additional warrants were issued upon the partial exercise by the underwriters of their over-allotment option, pursuant to an underwriting agreement, dated as of January 23, 2023 between the Company and Maxim Group LLC, as representative of the underwriters. The January Offering resulted in gross proceeds to the Company of approximately $5.2 million, before deducting underwriting discounts and commissions of 7% of the gross proceeds (3.5% of the gross proceeds in the case of certain identified investors) and estimated January Offering expenses.

 

Series C Redeemable Preferred Stock

 

In May 2017, the Company authorized Series C Redeemable Preferred Stock. Holders of Series C Redeemable Preferred Stock are entitled to receive dividends of 15% per year, payable in cash. For each of the three and six months ended June 30, 2024 and June 30, 2023, the Company recorded Series C Redeemable Preferred Stock dividends of $75 thousand and $150 thousand, respectively.

 

The Series C Redeemable Preferred Stock may be redeemed by the Company at the Company’s option in cash at any time, in whole or in part, upon payment of the stated value of the Series C Redeemable Preferred Stock and unpaid dividends. If a “fundamental change” occurs, the Series C Redeemable Preferred Stock shall be immediately redeemed in cash equal to the stated value of the Series C Redeemable Preferred Stock, and unpaid dividends. A fundamental change includes but is not limited to any change in the ownership of at least fifty percent of the voting stock; liquidation or dissolution; or the common stock ceases to be listed on the market upon which it currently trades.

 

The holders of the Series C Redeemable Preferred Stock are entitled to vote on any matter submitted to the stockholders of the Company for a vote. One share of Series C Redeemable Preferred Stock carries the same voting rights as one share of common stock.

 

A redeemable equity security is to be classified as temporary equity if it is conditionally redeemable upon the occurrence of an event that is not solely within the control of the issuer. Upon the determination that such events are probable, the equity security would be classified as a liability. Given the Series C Redeemable Preferred Stock contains a fundamental change provision, the security is considered conditionally redeemable. Therefore, the Company has classified the Series C Redeemable Preferred Stock as temporary equity in the balance sheets as of June 30, 2024 and December 31, 2023 until such time that events occur that indicate otherwise.

 

13

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 6 - STOCKHOLDERS’ EQUITY AND REDEEMABLE PREFERRED STOCK (CONTINUED)

 

Warrants

 

The following table summarizes the Company’s warrants outstanding and exercisable as of June 30, 2024 and December 31, 2023:

 

           Weighted     
       Weighted   Average     
       Average   Remaining   Aggregate 
   Number of   Exercise   Life   Intrinsic 
   Warrants   Price   In Years   Value 
                 
Outstanding and Exercisable at January 1, 2024   9,531,242   $39.44    3.72   $
          -
 
Expired warrants   (246,952)  $305.00    
 
    
 
 
Outstanding and Exercisable at June 30, 2024   9,284,290   $33.09    3.24   $
-
 

 

NOTE 7 - STOCK INCENTIVE PLANS

 

2023 Stock Incentive Plan

 

On March 7, 2023, the Company’s stockholders approved the 2023 Stock Incentive Plan (“2023 Plan”). The aggregate maximum number of shares of common stock that may be issued under the 2023 Plan is 68,723 shares for the 2023 fiscal year; thereafter, the maximum number is limited to 15% of the outstanding shares of common stock, calculated on the first business day of each fiscal quarter. As of June 30, 2024, the maximum number of shares of common stock that may be issued under the 2023 Plan is 322,562. Under the 2023 Plan, options which are forfeited or terminated, settled in cash in lieu of shares of common stock, or settled in a manner such that shares are not issued, will again immediately become available to be issued. If shares of common stock are withheld from payment of an award to satisfy tax obligations with respect to the award, those shares of common stock will be treated as shares that have been issued under the 2023 Plan and will not again be available for issuance.

 

During the three and six months ended June 30, 2024, the Company issued an aggregate of 1,375 stock options under the Company’s 2023 Stock Incentive Plan (the “2023 Plan”), vesting over a period of four years to employees with an exercise price of $1.06 per share and 625 stock options under the 2023 Plan, vesting over a period of four years to employees with an exercise price of $1.00 per share in consideration for services provided to the Company. In addition, an aggregate of 42,138 fully vested stock options were granted under the 2023 Plan to five non-employee directors at an exercise price of $1.06 per share, an aggregate of 16,854 fully vested stock options were granted under the 2023 Plan to three non-employee directors at an exercise price of $1.73 per share and an aggregate of 40,000 fully vested stock options were granted under the 2023 Plan to four non-employee directors at an exercise price of $1.00 per share in each case in consideration for services provided to the Company. The aggregate fair value of the shares issued to the directors was $85.4 thousand. As of June 30, 2024, the unrecognized compensation cost related to non-vested stock options was $26.4 thousand. 

 

During the three and six months ended June 30, 2024, 1,125 stock options were forfeited by participants under the 2023 Plan.

 

During the three and six months ended June 30, 2023, no stock options were forfeited by participants under the 2023 Plan.

 

14

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 7 - STOCK INCENTIVE PLANS (CONTINUED)

 

2017 Stock Incentive Plan

 

On August 24, 2017, the Company’s stockholders approved the 2017 Stock Incentive Plan (“2017 SIP”). The aggregate maximum number of shares of common stock that may be issued under the 2017 SIP is limited to 10% of the outstanding shares of common stock, calculated on the first business day of each fiscal year. Under the 2017 SIP, options which are forfeited or terminated, settled in cash in lieu of shares of common stock, or settled in a manner such that shares are not issued, will again immediately become available to be issued. If shares of common stock are withheld from payment of an award to satisfy tax obligations with respect to the award, those shares of common stock will be treated as shares that have been issued under the 2017 SIP and will not again be available for issuance. On March 7, 2023, the Company’s 2017 SIP was terminated upon the approval of the 2023 Plan at the Company’s special meeting of stockholders.

 

During the three and six months ended June 30, 2024, the Company did not issue any stock options under the 2017 SIP. As of June 30, 2024, the unrecognized compensation cost related to non-vested stock options was $17.9 thousand.

 

During the three months ended June 30, 2023, the Company did not issue any stock options. During the six months ended June 30, 2023, the Company issued 3,125 stock options vesting over four years to employees with an exercise price of $3.80 per share and a total aggregate fair value of $11 thousand. In addition, 10,528 fully vested stock options were granted to four non-employee Board directors at an exercise price of $3.80 per share. The aggregate fair value of the shares issued to the directors was $35 thousand.

 

During the six months ended June 30, 2024, 1,000 stock options were forfeited by participants under the 2017 SIP. During the three and six months ended June 30, 2023, 125 and 750 stock options were forfeited, respectively, by participants under the 2017 SIP. 

 

2013 Long-Term Stock Incentive Plan

 

On January 4, 2013, the Company’s stockholders approved the Company’s Long-Term Stock Incentive Plan (“2013 LTIP”). The maximum number of shares of common stock that may be issued under the 2013 LTIP, including stock awards, stock issued to the Company’s Board, and stock appreciation rights, is limited to 10% of the common shares outstanding on the first business day of any fiscal year. The Company’s 2013 LTIP expired in accordance with its terms on January 3, 2023.

 

During the three and six months ended June 30, 2024 and 2023, the Company did not issue any stock options under the 2013 LTIP. As of June 30, 2024, the unrecognized compensation cost related to non-vested stock options was $0.2 million.

 

During the three and six months ended June 30, 2024, no stock options were forfeited by participants under the 2013 LTIP. During the three months ended June 30, 2023, no stock options were forfeited and during the six months ended June 30, 2023, 1,250 stock options were forfeited by participants under the 2013 LTIP.

 

Stock based Compensation Expense 

 

Total stock based compensation expense during the three and six months ended June 30, 2024 pertaining to awards under the 2023 Plan, the 2017 SIP and the 2013 LTIP amounted to $0.4 million and $0.8 million, respectively. Total stock based compensation expense during the three and six months ended June 30, 2023, pertaining to awards under the 2017 SIP and 2013 LTIP amounted to $0.4 million and $0.8 million, respectively.

 

15

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 8 - COMMITMENTS AND CONTINGENCIES

 

LEGAL MATTERS

 

From time to time, the Company may be involved in various claims and legal actions arising in the ordinary course of our business. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company or any of our subsidiaries, threatened against or affecting our company, or any of our subsidiaries in which an adverse decision could have a material adverse effect upon our business, operating results, or financial condition.

 

COMMITMENTS

 

The Company leases warehouse space and equipment, in the U.S., which is classified as operating leases expiring at various dates. The Company determines if an arrangement qualifies as a lease at the lease inception. Operating lease liabilities are recorded based on the present value of the future lease payments over the lease term, assessed as of the commencement date. The Company’s real estate lease is for a fulfillment center, with a lease term of 5 years expiring in August 2025. The Company has elected to account for the lease and non-lease components (insurance and property taxes) as a single lease component for its real estate leases. Lease payments, which includes lease components and non-lease components, are included in the measurement of the Company’s lease liabilities to the extent that such payments are either fixed amounts or variable amounts based on a rate or index (fixed in substance) as stipulated in the lease contract. Any actual costs in excess of such amounts are expensed as incurred as variable lease cost.

 

The Company’s lease agreements generally do not specify an implicit borrowing rate, and as such, the Company uses its incremental borrowing rate to calculate the present value of the future lease payments. The discount rate represents a risk-adjusted rate on a secured basis and is the rate at which the Company would borrow funds to satisfy the scheduled lease liability payment streams. The Company entered into a new five-year lease agreement in June 2020 for new warehouse space located in Louisville, Kentucky. The Right of Use (“ROU”) asset value added as a result of this new lease agreement was $0.3 million. The Company’s ROU asset and lease liability accounts reflect the inclusion of this lease in the Company’s balance sheets as of June 30, 2024 and December 31, 2023. The current monthly rent of $6.6 thousand increased from the commencement amount of $6.4 thousand in September 2023 in accordance with the lease agreement, which requires that the rent increase 3% annually.

 

The Company’s lease agreements include options for the Company to either renew or early terminate the lease. Renewal options are reviewed at lease commencement to determine if such options are reasonably certain of being exercised, which could impact the lease term. When determining if a renewal option is reasonably certain of being exercised, the Company considers several factors, including significance of leasehold improvements on the property, whether the asset is difficult to replace, or specific characteristics unique to the lease that would make it reasonably certain that the Company would exercise the option. In most cases, the Company has concluded that renewal and early termination options are not reasonably certain of being exercised by the Company and thus not included in the Company’s ROU asset and lease liability.

 

16

 

 

LogicMark, Inc.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 8 - COMMITMENTS AND CONTINGENCIES (CONTINUED)

 

For the three and six months ended June 30, 2024, total operating lease cost was $19.2 thousand and $38.5 thousand, respectively, and was recorded in direct operating costs. Operating lease cost for the three and six months ended June 30, 2023 amounted to $25.2 thousand and $50.7 thousand and was recorded in direct operating costs and general and administrative expenses. Operating lease cost is recognized on a straight-line basis over the lease term. The following summarizes (i) the future minimum undiscounted lease payments under the non-cancelable lease for each of the next three years and thereafter, incorporating the practical expedient to account for lease and non-lease components as a single lease component for our existing real estate lease, (ii) a reconciliation of the undiscounted lease payments to the present value of the lease liabilities, and (iii) the lease-related account balances on the Company’s balance sheet as of June 30, 2024:

 

Year Ending December 31,    
2024 (for the remainder of 2024)   40,400 
2025   54,400 
Total future minimum lease payments  $94,800 
Less imputed interest   (7,302)
Total present value of future minimum lease payments  $87,498 

 

As of June 30, 2024    
Operating lease right-of-use assets  $82,298 
      
Accrued expenses  $74,116 
Other long-term liabilities   13,382 
   $87,498 

 

As of June 30, 2024    
Weighted Average Remaining Lease Term   1.17 
Weighted Average Discount Rate   13.00%

 

NOTE 9 – SUBSEQUENT EVENT

 

Best Efforts Public Offering

 

On August 5, 2024 (the “Closing Date”), the Company, in connection with a best efforts public offering (the “Offering”), sold to certain purchasers an aggregate of (x) 1,449,916 units of the Company (the “Units”) at an offering price of $0.4654 per Unit, consisting of (i) 1,449,916 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”) (ii) 1,449,916 of the Company’s Series A warrants to purchase Common Stock, exercisable for up to 1,449,916 shares of Common Stock (the “August Series A Warrants”), and (iii) 1,449,916 of the Company’s Series B warrants to purchase Common Stock, exercisable for up to 1,449,916 shares of Common Stock (the “August Series B Warrants”); and (y) 8,220,084 pre-funded units of the Company (the “Pre-Funded Units”) at an offering price $0.4644 per Pre-Funded Unit, consisting of (i) 8,220,084 pre-funded common stock purchase warrants exercisable for up to 8,220,084 shares of Common Stock at $0.001 per share, (the “August Pre-Funded Warrants”), (ii) 8,220,084 August Series A Warrants and (iii) 8,220,084 August Series B Warrants, pursuant to the Company’s Form S-1 registration statement, as amended (File No. 333-279133), declared effective by the SEC on August 1, 2024 and securities purchase agreements, dated August 2, 2024, between the Company and each of the purchasers signatory thereto (the “Purchasers”). On the Closing Date, the Company received gross proceeds of approximately $4.5 million, before deducting placement agent discounts and commissions and estimated Offering expenses. The Company intends to use the net proceeds from the Offering for continued new product development, working capital and other general corporate purposes.

 

In addition, as of August 12, 2024, the Purchasers exercised their August Pre-Funded Warrants for an aggregate of 2,421,930 shares of Common Stock.

 

17

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of our financial condition and results of operations for the three and six months ended June 30, 2024, should be read together with our condensed financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q for the three and six months ended June 30, 2024 (this “Form 10-Q”). This discussion and other disclosure in this Form 10-Q contain forward-looking statements and information relating to our business, including without limitation those related to current and future compliance with the listing requirements of The Nasdaq Stock Market LLC, that reflect our current views and assumptions concerning future events and is subject to risks and uncertainties that may cause our or our industry’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These forward-looking statements speak only as of the date of this Form 10-Q. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, or achievements. Except as required by applicable law, including the securities laws of the United States, we expressly disclaim any obligation or undertaking to disseminate any update or revisions of any of the forward-looking statements to reflect any change in our expectations with regard thereto or to conform to these statements to actual results.

 

Overview

 

LogicMark, Inc. provides PERS, health communications devices, and Internet of Things technology that creates a connected care platform. The Company’s devices provide people with the ability to receive care at home and age independently. The Company’s PERS devices incorporate two-way voice communication technology directly in the medical alert pendant and providing life-saving technology at a consumer-friendly price point aimed at everyday consumers. These PERS technologies, as well as other personal safety devices, are sold direct-to-consumer through Company’s eCommerce website and Amazon.com, through dealers and distributors, as well as directly to the United States Veterans Health Administration. The Company was awarded a contract by the U.S. General Services Administration that enables the Company to distribute its products to federal, state, and local governments.

  

Recent Developments

 

Best Efforts Public Offering

 

On August 5, 2024 (the “Closing Date”), the Company, in connection with a best efforts public offering (the “Offering”), sold to certain purchasers an aggregate of (x) 1,449,916 units of the Company (the “Units”) at an offering price of $0.4654 per Unit, consisting of (i) 1,449,916 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”) (ii) 1,449,916 of the Company’s Series A warrants to purchase Common Stock, exercisable for up to 1,449,916 shares of Common Stock (the “Series A Warrants”), and (iii) 1,449,916 of the Company’s Series B warrants to purchase Common Stock, exercisable for up to 1,449,916 shares of Common Stock (the “Series B Warrants” and, together with the Series A Warrants, the “Warrants”); and (y) 8,220,084 pre-funded units of the Company (the “Pre-Funded Units”) at an offering price $0.4644 per Pre-Funded Unit, consisting of (i) 8,220,084 pre-funded common stock purchase warrants exercisable for up to 8,220,084 shares of Common Stock at $0.001 per share, (the “Pre-Funded Warrants”), (ii) 8,220,084 Series A Warrants and (iii) 8,220,084 Series B Warrants, pursuant to the Company’s Form S-1 registration statement, as amended (File No. 333-279133), declared effective by the SEC on August 1, 2024 (the “Registration Statement”) and securities purchase agreements, dated August 2, 2024, between the Company and each of the purchasers signatory thereto (the “Purchasers”). On the Closing Date, the Company received gross proceeds of approximately $4.5 million, before deducting placement agent discounts and commissions and estimated Offering expenses. The Company intends to use the net proceeds from the Offering for continued new product development, working capital and other general corporate purposes. In connection with the Offering, on August 2, 2024, the Company also entered into a placement agency agreement with Roth Capital Partners, LLC (“Roth”), pursuant to which it paid Roth cash fees equal to 7.0% of the gross proceeds received by the Company from the Offering and $75,000 in fees and expenses.

 

In addition, as of August 12, 2024, the Purchasers exercised their Pre-Funded Warrants for an aggregate of 2,421,930 shares of Common Stock. For additional information regarding the Offering, see the Current Report on Form 8-K filed by the Company with the SEC on August 5, 2024.

 

Results of Operations

 

Three and six months ended June 30, 2024, compared to the three and six months ended June 30, 2023.

 

Revenue, Cost of Goods Sold, and Gross Profit

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2024   2023   2024   2023 
Revenue  $2,336,268   $2,326,995   $4,947,351   $5,136,713 
Cost of Goods Sold   781,318    727,276    1,625,183    1,674,445 
Gross Profit  $1,554,950   $1,599,719   $3,322,168   $3,462,268 
Profit Margin   67%   69%   67%   67%

 

18

 

  

We did not experience a material fluctuation for the three months ended June 30, 2024, compared to the same period ended June 30, 2023. We experienced a 4% decrease in revenue for the six months ended June 30, 2024, as compared to the same period ended June 30, 2023. The primary decrease in revenue was due to lower sales of our Freedom Alert and Guardian Alert hardware.

 

Gross profit margin was 67% for the three months ended June 30, 2024, down from 69% for the three months ended June 30, 2023, as a result of an increase in cost of goods sold related to an increase in costs of our Guardian Alert and Freedom Alert hardware due to an increase in sales, new hardware cost and software monitoring costs for our newly released hardware in 2024, packaging and materials cost, and an increase in warehouse labor. No material fluctuations were noted for the six months ended June 30, 2024, compared to the same period ended June 30, 2023.

 

Operating Expenses

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
Operating Expenses  2024   2023   2024   2023 
Direct operating cost  $320,660   $312,426   $651,580   $575,228 
Advertising costs   135,220    85,277    287,433    133,393 
Selling and marketing   605,493    517,931    1,193,031    983,466 
Research and development   133,556    250,266    307,458    564,154 
General and administrative   1,982,997    2,443,860    3,881,960    4,857,619 
Other expense   69,932    50,646    153,758    78,964 
Depreciation and amortization   377,974    215,703    723,525    431,701 
Total Expenses  $3,625,832   $3,876,109   $7,198,745   $7,624,525 

 

Direct Operating Cost

 

No material fluctuations were noted for the three months ended June 30, 2024, compared to the same period ended June 30, 2023. The $0.1 million increase in direct operating cost for the six months ended June 30, 2024, compared to the same period ended June 30, 2023, was primarily driven by the direct operating fees incurred from sales through Amazon.com.

 

Advertising Costs

 

The $50.0 thousand and $0.2 million increase in advertising costs for the three and six months ended June 30, 2024, compared to the same periods ended June 30, 2023, was primarily driven by the cost of advertising related to the sale of our hardware through Amazon.com and a continued expansion in social media advertising.

 

Selling and Marketing

 

The $0.1 million and $0.2 million increase in selling and marketing expenses for the three and six months ended June 30, 2024, compared to the same periods ended June 30, 2023, was driven by the additional sales personnel and consultants and their related expenses.

  

Research and Development

 

The $0.1 million and $0.3 million decrease in research and development expenses for the three and six months ended June 30, 2024, compared to the same periods ended June 30, 2023, was driven by an increase in capitalization of salaries and wages due to the development of new hardware and software in the pipeline and a reduction in product development and engineering costs as new products have been released.

 

19

 

 

General and Administrative

 

General and administrative costs decreased $0.5 million and $1.0 million for the three and six months ended June 30, 2024, compared to the same periods ended June 30, 2023, which was driven by lower recruiting, accounting costs, consulting costs and legal fees.

 

Other Income

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
Other Income  2024   2023   2024   2023 
Interest income  $32,025   $8,510   $93,177   $60,938 
Total Other Income  $32,025   $8,510   $93,177   $60,938 

  

During each of the three and six months ended June 30, 2024 and 2023, the Company recorded other income, which was driven by the generation of interest income from its cash balances.

 

Liquidity and Capital Resources

 

Sources of Liquidity

 

The Company generated an operating loss of $3.9 million and a net loss of $3.8 million for the six months ended June 30, 2024. As of June 30, 2024, the Company had cash and cash equivalents of $3.0 million. As of June 30, 2024, the Company had working capital of $2.8 million.

 

Given our cash position as of June 30, 2024, the proceeds from our common stock, pre-funded warrant and warrant issuance in August 2024, and our projected cash flow from operations, we believe we will have sufficient capital to sustain operations for the twelve months from the date of the filing of our condensed financial statements. We may also raise funds through equity or debt offerings to accelerate the execution of our long-term strategic plan to develop and commercialize our new products.

 

Cash Flows

 

Cash Used in Operating Activities

 

During the six months ended June 30, 2024, net cash used in operating activities was $2.7 million. During the six months ended June 30, 2023, net cash used in operating activities was $3.2 million. Our primary ongoing uses of operating cash relate to payments to vendors, salaries and related expenses for our employees and consulting and professional fees. Our vendors and consultants generally provide us with normal trade payment terms (net 30).

 

20

 

 

Cash Used in Investing Activities

 

During the six months ended June 30, 2024, we purchased $16.7 thousand in equipment and website development costs and invested $0.6 million in product development and software development. During the six months ended June 30, 2023, we purchased $49 thousand in equipment and invested $0.5 million in product development and software development.

 

Cash (Used in) Provided by Financing Activities

 

   Six Months Ended
June 30,
 
Cash flows from Financing Activities  2024   2023 
Proceeds from sale of common stock and warrants  $-   $5,211,428 
Fees paid in connection with equity offerings   (98,678)   (816,017)
Common stock withheld to pay taxes   (4,235)   - 
Warrants exercised for common stock   -    162,494 
Series C redeemable preferred stock dividends   (150,000)   (150,000)
Net Cash (Used in) Provided by Financing Activities  $(252,913)  $4,407,905 

 

During the six months ended June 30, 2024, we incurred $98.7 thousand in fees for the warrant inducement transaction that occurred in November 2023 and offering costs related to the Offering that closed on August 5, 2024. During the three and six months ended June 30, 2023, we completed a registered public offering of units and pre-funded units, consisting of common stock, warrants and pre-funded warrants, whereby we received proceeds of $5.2 million and paid fees of $0.8 million. During the six months ended June 30, 2024 and 2023, we paid Series C Redeemable Preferred Stock dividends amounting to $0.2 million each period.

 

Impact of Inflation

 

We believe that our business has been modestly impacted by inflationary trends during the past three fiscal years. However, continued domestic inflation may increase our cost of fulfilment in the 2024 fiscal year through higher labor and shipping costs, as well as our operating and overhead expenses. Should inflation become a continuing factor in the worldwide economy, it may increase the cost of purchasing products from our contract manufacturers in Asia, as well as the cost of certain raw materials, component parts and labor used in the production of our products. We have been able to maintain our profit margins through high productivity, stable supply chain management, efficiency improvements, reduction programs and selected price increases.

 

Off-Balance Sheet Arrangements

 

We do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not have any undisclosed borrowings or debt, and we have not entered into any synthetic leases. We are, therefore, not materially exposed to any financing, liquidity, market, or credit risk that could arise if we had engaged in such relationships.

 

Critical Accounting Policies

 

There were no significant changes to our critical accounting policies and estimates during the three and six months ended June 30, 2024, from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023.

 

21

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

We are not required to provide the information required by this Item 3 as we are a smaller reporting company.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we are required to perform an evaluation of our disclosure controls and procedures, as such term is defined in Rule 13a-15(e) under the Exchange Act, as of June 30, 2024. Management has concluded that our disclosure controls and procedures were effective as of June 30, 2024 to provide reasonable assurance that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in the Company’s internal control over financial reporting that occurred during the six months ended June 30, 2024 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

 

Limitations of the Effectiveness of Internal Control

 

Our management, including our Chief Executive Officer and Chief Financial Officer, do not expect that our disclosure controls and procedures will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include, but are not limited to, the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple errors. Additionally, controls can be circumvented by the individual acts of a person, by collusion of two or more people, or by management override of the control. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

22

 

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

From time to time, we may become subject to legal proceedings, claims, or litigation arising in the ordinary course of business. We are not presently a party to any other legal proceedings that in the opinion of our management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows.

 

Item 1A. Risk Factors

 

As a smaller reporting company, we are not required to provide the information required by this item. 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

During the three months ended June 30, 2024, the Company issued an aggregate of 625 stock options under the Company’s 2023 Stock Incentive Plan (the “2023 Plan”), vesting over a period of four years to employees with an exercise price of $1.00 per share, in consideration for services provided to the Company. In addition, an aggregate of 40,000 fully vested stock options were granted under the 2023 Plan to four non-employee directors at an exercise price of $1.00 per share in each case in consideration for services provided to the Company.

 

The sale and the issuance of the foregoing securities were offered and sold in reliance upon the exemption from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, for transactions not involving any public offering. No underwriter participated in the offer and sale of these securities, no commission or other remuneration was paid or given directly or indirectly in connection therewith, and there was no general solicitation or advertising for securities issued in reliance upon such exemption.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits

 

Exhibit    
Number   Description
31.1*   Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

 

* Filed herewith.

 

23

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  LogicMark, Inc.
   
Date: August 14, 2024 By: /s/ Chia-Lin Simmons
    Chia-Lin Simmons
    Chief Executive Officer
    (Principal Executive Officer)
     
Date: August 14, 2024 By: /s/ Mark Archer
    Mark Archer
    Chief Financial Officer
    (Principal Financial Officer and
Principal Accounting Officer)

 

 

24

 

 

0.96 1.81 1.83 3.73 1139437 1282794 2170564 2190716 false --12-31 Q2 0001566826 0001566826 2024-01-01 2024-06-30 0001566826 2024-08-12 0001566826 2024-06-30 0001566826 2023-12-31 0001566826 lgmk:SeriesCRedeemablePreferredStockMember 2024-06-30 0001566826 lgmk:SeriesCRedeemablePreferredStockMember 2023-12-31 0001566826 us-gaap:SeriesFPreferredStockMember 2024-06-30 0001566826 us-gaap:SeriesFPreferredStockMember 2023-12-31 0001566826 2024-04-01 2024-06-30 0001566826 2023-04-01 2023-06-30 0001566826 2023-01-01 2023-06-30 0001566826 us-gaap:PreferredStockMember 2024-03-31 0001566826 us-gaap:CommonStockMember 2024-03-31 0001566826 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001566826 us-gaap:RetainedEarningsMember 2024-03-31 0001566826 2024-03-31 0001566826 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001566826 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001566826 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001566826 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001566826 us-gaap:PreferredStockMember 2024-06-30 0001566826 us-gaap:CommonStockMember 2024-06-30 0001566826 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001566826 us-gaap:RetainedEarningsMember 2024-06-30 0001566826 us-gaap:PreferredStockMember 2023-12-31 0001566826 us-gaap:CommonStockMember 2023-12-31 0001566826 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001566826 us-gaap:RetainedEarningsMember 2023-12-31 0001566826 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001566826 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001566826 us-gaap:PreferredStockMember 2024-01-01 2024-06-30 0001566826 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0001566826 us-gaap:PreferredStockMember 2023-03-31 0001566826 us-gaap:CommonStockMember 2023-03-31 0001566826 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001566826 us-gaap:RetainedEarningsMember 2023-03-31 0001566826 2023-03-31 0001566826 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001566826 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001566826 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001566826 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001566826 us-gaap:PreferredStockMember 2023-06-30 0001566826 us-gaap:CommonStockMember 2023-06-30 0001566826 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001566826 us-gaap:RetainedEarningsMember 2023-06-30 0001566826 2023-06-30 0001566826 us-gaap:PreferredStockMember 2022-12-31 0001566826 us-gaap:CommonStockMember 2022-12-31 0001566826 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001566826 us-gaap:RetainedEarningsMember 2022-12-31 0001566826 2022-12-31 0001566826 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001566826 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001566826 us-gaap:PreferredStockMember 2023-01-01 2023-06-30 0001566826 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001566826 us-gaap:SubsequentEventMember 2024-08-05 2024-08-05 0001566826 us-gaap:CustomerRelationshipsMember lgmk:LogicMarkInvestmentPartnersMember 2024-06-30 0001566826 us-gaap:PatentsMember lgmk:LogicMarkInvestmentPartnersMember 2024-06-30 0001566826 us-gaap:TrademarksMember lgmk:LogicMarkInvestmentPartnersMember 2024-06-30 0001566826 us-gaap:PatentsMember lgmk:LogicMarkInvestmentPartnersMember 2023-12-31 0001566826 us-gaap:TrademarksMember lgmk:LogicMarkInvestmentPartnersMember 2023-12-31 0001566826 us-gaap:CustomerRelationshipsMember lgmk:LogicMarkInvestmentPartnersMember 2023-12-31 0001566826 lgmk:TwoThousandTwentyFiveMember 2024-06-30 0001566826 lgmk:TwoThousandTwentySixMember 2024-06-30 0001566826 lgmk:TwoThousandTwentySevenMember 2024-06-30 0001566826 lgmk:TwoThousandTwentyEightMember 2024-06-30 0001566826 us-gaap:WarrantMember 2024-06-30 0001566826 us-gaap:WarrantMember 2023-06-30 0001566826 us-gaap:SoftwareDevelopmentMember 2024-04-01 2024-06-30 0001566826 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2024-04-01 2024-06-30 0001566826 us-gaap:SoftwareDevelopmentMember 2024-01-01 2024-06-30 0001566826 us-gaap:RelatedPartyMember 2023-01-01 2023-06-30 0001566826 us-gaap:EquipmentMember 2024-06-30 0001566826 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2024-06-30 0001566826 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2024-06-30 0001566826 lgmk:WebsiteAndOtherMember 2024-06-30 0001566826 us-gaap:WarrantMember 2023-11-21 2023-11-21 0001566826 lgmk:SeptemberTwoThousandTwentyOneWarrantsMember 2023-11-21 2023-11-21 0001566826 lgmk:JanuaryTwoThousandTwentyThreeWarrantsMember 2023-11-21 2023-11-21 0001566826 lgmk:SeriesAWarrantMember 2023-11-21 2023-11-21 0001566826 lgmk:SeriesAWarrantMember 2023-11-21 0001566826 lgmk:SeriesBWarrantsMember 2023-11-21 2023-11-21 0001566826 lgmk:SeriesBWarrantsMember 2023-11-21 0001566826 lgmk:JanuaryTwoThousandTwentyThreeOfferingMember 2023-01-25 2023-01-25 0001566826 lgmk:JanuaryTwoThousandTwentyThreeOfferingMember 2023-01-25 0001566826 lgmk:JanuaryTwoThousandTwentyThreeOfferingMember us-gaap:CommonStockMember 2023-01-25 0001566826 lgmk:JanuaryTwoThousandTwentyThreeOfferingMember lgmk:PrefundedWarrantsMember 2023-01-25 0001566826 lgmk:JanuaryTwoThousandTwentyThreeOfferingMember us-gaap:WarrantMember 2023-01-25 2023-01-25 0001566826 lgmk:JanuaryTwoThousandTwentyThreeOfferingMember us-gaap:WarrantMember 2023-01-25 0001566826 lgmk:SeriesCRedeemablePreferredStockMember 2017-05-31 2017-05-31 0001566826 lgmk:SeriesCRedeemablePreferredStockMember 2024-01-01 2024-06-30 0001566826 lgmk:SeriesCRedeemablePreferredStockMember 2024-04-01 2024-06-30 0001566826 lgmk:SeriesCRedeemablePreferredStockMember 2023-01-01 2023-06-30 0001566826 lgmk:SeriesCRedeemablePreferredStockMember 2023-04-01 2023-06-30 0001566826 us-gaap:WarrantMember 2023-12-31 0001566826 us-gaap:WarrantMember 2024-01-01 2024-06-30 0001566826 lgmk:TwoThousandAndTwentyThreeStockIncentivePlanMember 2023-03-07 2023-03-07 0001566826 lgmk:TwoThousandAndTwentyThreeStockIncentivePlanMember 2024-01-01 2024-06-30 0001566826 lgmk:TwoThousandAndTwentyThreeStockIncentivePlanMember 2024-04-01 2024-06-30 0001566826 lgmk:TwoThousandAndTwentyThreeStockIncentivePlanMember 2024-06-30 0001566826 lgmk:FiveNonEmployeeBoardDirectorsMember lgmk:TwoThousandAndTwentyThreeStockIncentivePlanMember 2024-06-30 0001566826 lgmk:NonemployeeBoardDirectorsMember lgmk:TwoThousandAndTwentyThreeStockIncentivePlanMember 2024-01-01 2024-06-30 0001566826 lgmk:NonemployeeBoardDirectorsMember lgmk:TwoThousandAndTwentyThreeStockIncentivePlanMember 2024-06-30 0001566826 lgmk:TwoThousandAndSeventeenStockIncentivePlanMember 2017-08-24 2017-08-24 0001566826 lgmk:TwoThousandSeventeenStockIncentivePlanMember 2024-01-01 2024-06-30 0001566826 lgmk:TwoThousandAndSeventeenStockIncentivePlanMember 2024-01-01 2024-06-30 0001566826 lgmk:TwoThousandAndSeventeenStockIncentivePlanMember 2024-06-30 0001566826 lgmk:TwoThousandAndSeventeenStockIncentivePlanMember 2023-01-01 2023-06-30 0001566826 lgmk:TwoThousandAndSeventeenStockIncentivePlanMember 2024-04-01 2024-06-30 0001566826 lgmk:NonemployeeBoardDirectorsMember lgmk:TwoThousandAndSeventeenStockIncentivePlanMember 2024-06-30 0001566826 lgmk:NonemployeeBoardDirectorsMember lgmk:TwoThousandAndSeventeenStockIncentivePlanMember 2024-04-01 2024-06-30 0001566826 lgmk:TwoThousandAndSeventeenStockIncentivePlanMember 2023-04-01 2023-06-30 0001566826 lgmk:TwoThousandAndThirteenLongTermStockIncentivePlanMember 2013-01-04 2013-01-04 0001566826 lgmk:TwoThousandAndThirteenLongTermStockIncentivePlanMember 2024-01-01 2024-06-30 0001566826 lgmk:LouisvilleKentuckyMember 2024-01-01 2024-06-30 0001566826 2023-09-30 2023-09-30 0001566826 us-gaap:SubsequentEventMember 2024-08-05 0001566826 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-08-05 2024-08-05 0001566826 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-08-05 0001566826 lgmk:SeriesAWarrantsMember us-gaap:SubsequentEventMember 2024-08-05 2024-08-05 0001566826 lgmk:SeriesBWarrantsMember us-gaap:SubsequentEventMember 2024-08-05 2024-08-05 0001566826 lgmk:AugustSeriesBWarrantsMember us-gaap:SubsequentEventMember 2024-08-05 0001566826 lgmk:PrefundedUnitsMember us-gaap:SubsequentEventMember 2024-08-05 0001566826 lgmk:PrefundedCommonStockMember us-gaap:SubsequentEventMember 2024-08-05 0001566826 lgmk:AugustPreFundedWarrantsMember us-gaap:SubsequentEventMember 2024-08-05 0001566826 lgmk:AugustPreFundedWarrantsMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-08-05 0001566826 lgmk:AugustSeriesAWarrantsMember us-gaap:SubsequentEventMember 2024-08-05 0001566826 lgmk:AugustPreFundedWarrantsMember us-gaap:SubsequentEventMember 2024-08-12 2024-08-12 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

 

CERTIFICATION

OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Chia-Lin Simmons, as the principal executive officer of the registrant, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q for the quarter ended June 30, 2024, of LogicMark, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2024

By: /s/ Chia-Lin Simmons
    Chia-Lin Simmons
    Chief Executive Officer
    (Duly Authorized Officer and
Principal Executive Officer)

 

 

Exhibit 31.2

 

CERTIFICATION

OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Mark Archer, as the principal financial officer of the registrant, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q for the quarter ended June 30, 2024, of LogicMark, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2024

  /s/ Mark Archer
    Mark Archer
    Chief Financial Officer
    (Duly Authorized Officer and
Principal Financial and Accounting Officer)

 

Exhibit 32.1

 

CERTIFICATION

OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of LogicMark, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Chia-Lin Simmons, Chief Executive Officer of LogicMark, Inc., certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 14, 2024

By: /s/ Chia-Lin Simmons
    Chia-Lin Simmons
    Chief Executive Officer
    (Duly Authorized Officer and
    Principal Executive Officer)

 

 

 

Exhibit 32.2

 

CERTIFICATION

OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of LogicMark, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Archer, Chief Financial Officer of LogicMark, Inc., certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 14, 2024

By: /s/ Mark Archer
    Mark Archer
    Chief Financial Officer
    (Duly Authorized Officer and
    Principal Financial Officer)

 

 

v3.24.2.u1
Cover - shares
6 Months Ended
Jun. 30, 2024
Aug. 12, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Jun. 30, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Entity Information [Line Items]    
Entity Registrant Name LogicMark, Inc.  
Entity Central Index Key 0001566826  
Entity File Number 001-36616  
Entity Tax Identification Number 46-0678374  
Entity Incorporation, State or Country Code NV  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 2801 Diode Lane  
Entity Address, City or Town Louisville  
Entity Address, State or Province KY  
Entity Address, Postal Zip Code 40299  
Entity Phone Fax Numbers [Line Items]    
City Area Code (502)  
Local Phone Number 442-7911  
Entity Listings [Line Items]    
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol LGMK  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   6,065,383
v3.24.2.u1
Condensed Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 2,959,815 $ 6,398,164
Accounts receivable, net 11,918 13,647
Inventory 678,537 1,177,456
Prepaid expenses and other current assets 773,894 460,177
Total Current Assets 4,424,164 8,049,444
Property and equipment, net 161,501 203,333
Right-of-use assets, net 82,298 113,761
Product development costs, net of amortization of $216,151 and $68,801, respectively 1,368,120 1,269,021
Software development costs, net of amortization of $161,775 and $23,354, respectively 1,637,875 1,299,901
Goodwill 3,143,662 3,143,662
Other intangible assets, net of amortization of $6,047,407 and $5,666,509, respectively 2,557,160 2,938,058
Total Assets 13,374,780 17,017,180
Current Liabilities    
Accounts payable 796,815 901,624
Accrued expenses 767,717 1,151,198
Deferred revenue 25,069
Total Current Liabilities 1,589,601 2,052,822
Other long-term liabilities 13,382 51,842
Total Liabilities 1,602,983 2,104,664
Commitments and Contingencies (Note 8)
Stockholders’ Equity    
Preferred stock
Common stock, par value $0.0001 per share: 100,000,000 shares authorized; 2,193,587 and 2,150,412 issued and outstanding as of June 30, 2024 and December 31, 2023, respectively 220 216
Additional paid-in capital 113,589,568 112,946,891
Accumulated deficit (103,944,291) (100,160,891)
Total Stockholders’ Equity 9,964,497 13,105,216
Total Liabilities, Series C Redeemable Preferred Stock and Stockholders’ Equity 13,374,780 17,017,180
Series C Redeemable Preferred Stock    
Series C Redeemable Preferred Stock    
Series C redeemable preferred stock, par value $0.0001 per share: 2,000 shares designated; 10 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively 1,807,300 1,807,300
Series F Preferred Stock    
Stockholders’ Equity    
Preferred stock $ 319,000 $ 319,000
v3.24.2.u1
Condensed Balance Sheets (Unaudited) (Parentheticals) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Product development costs, net of amortization (in Dollars) $ 216,151 $ 68,801
Software development costs, net of amortization (in Dollars) 161,775 23,354
Other intangible assets, net of amortization (in Dollars) $ 6,047,407 $ 5,666,509
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares designated 10,000,000 10,000,000
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 2,193,587 2,150,412
Common stock, shares outstanding 2,193,587 2,150,412
Series C Redeemable Preferred Stock    
Temporary equity, par value (in Dollars per share) $ 0.0001 $ 0.0001
Temporary equity, shares designated 2,000 2,000
Temporary equity, shares issued 10 10
Preferred stock, shares outstanding 10 10
Series F Preferred Stock    
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares designated 1,333,333 1,333,333
Preferred stock, shares issued 106,333 106,333
Preferred stock, shares outstanding 106,333 106,333
Preferred stock, aggregate liquidation preference (in Dollars) $ 319,000 $ 319,000
v3.24.2.u1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenues $ 2,336,268 $ 2,326,995 $ 4,947,351 $ 5,136,713
Costs of goods sold 781,318 727,276 1,625,183 1,674,445
Gross Profit 1,554,950 1,599,719 3,322,168 3,462,268
Operating Expenses        
Direct operating cost 320,660 312,426 651,580 575,228
Advertising costs 135,220 85,277 287,433 133,393
Selling and marketing 605,493 517,931 1,193,031 983,466
Research and development 133,556 250,266 307,458 564,154
General and administrative 1,982,997 2,443,860 3,881,960 4,857,619
Other expense 69,932 50,646 153,758 78,964
Depreciation and amortization 377,974 215,703 723,525 431,701
Total Operating Expenses 3,625,832 3,876,109 7,198,745 7,624,525
Operating Loss (2,070,882) (2,276,390) (3,876,577) (4,162,257)
Other Income        
Interest income 32,025 8,510 93,177 60,938
Total Other Income 32,025 8,510 93,177 60,938
Loss before Income Taxes (2,038,857) (2,267,880) (3,783,400) (4,101,319)
Income tax expense
Net Loss (2,038,857) (2,267,880) (3,783,400) (4,101,319)
Preferred stock dividends (75,000) (75,000) (150,000) (150,000)
Net Loss Attributable to Common Stockholders $ (2,113,857) $ (2,342,880) $ (3,933,400) $ (4,251,319)
Net Loss Attributable to Common Stockholders Per Share - Basic (in Dollars per share) $ (0.96) $ (1.83) $ (1.81) $ (3.73)
Weighted Average Number of Common Shares Outstanding - Basic (in Shares) 2,190,716 1,282,794 2,170,564 1,139,437
v3.24.2.u1
Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Net Loss Attributable to Common Stockholders Per Share - Diluted $ (0.96) $ (1.83) $ (1.81) $ (3.73)
Weighted Average Number of Common Shares Outstanding - Diluted 2,190,716 1,282,794 2,170,564 1,139,437
v3.24.2.u1
Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 520,000 $ 48 $ 106,070,253 $ (85,610,282) $ 20,980,019
Balance (in Shares) at Dec. 31, 2022 173,333 480,447      
Stock based compensation expense     792,300   792,300
Shares issued as stock based compensation   $ 1 2,202   2,203
Shares issued as stock based compensation (in Shares)   5,000      
Sale of common stock, pre-funded warrants and warrants pursuant to a registration statement on Form S-1 $ 70 5,211,358 5,211,428
Sale of common stock, pre-funded warrants and warrants pursuant to a registration statement on Form S-1 (in Shares)   701,250      
Fees incurred in connection with equity offerings     (816,017)   (816,017)
Fractional shares issued in the 1-for-20 stock split $ 4 (4)
Fractional shares issued in the 1-for-20 stock split (in Shares)   40,228      
Warrants exercised for common stock $ 6 162,488 162,494
Warrants exercised for common stock (in Shares)   64,481      
Series F Preferred stock converted to common stock $ (201,000) $ 3 200,997
Series F Preferred stock converted to common stock (in Shares) (67,000) 27,089      
Common stock issued as Series F Preferred stock dividends $ 1 48,388 48,389
Common stock issued as Series F Preferred stock dividends (in Shares)   6,522      
Series C Preferred stock dividends     (150,000)   (150,000)
Net loss       (4,101,319) (4,101,319)
Balance at Jun. 30, 2023 $ 319,000 $ 133 111,521,965 (89,711,601) 22,129,497
Balance (in Shares) at Jun. 30, 2023 106,333 1,325,017      
Balance at Mar. 31, 2023 $ 319,000 $ 123 111,079,795 (87,443,721) 23,955,197
Balance (in Shares) at Mar. 31, 2023 106,333 1,220,308      
Stock based compensation expense     365,458   365,458
Fees incurred in connection with equity offerings     (10,772)   (10,772)
Fractional shares issued in the 1-for-20 stock split $ 4 (4)
Fractional shares issued in the 1-for-20 stock split (in Shares)   40,228      
Warrants exercised for common stock $ 6 162,488 162,494
Warrants exercised for common stock (in Shares)   64,481      
Series C Preferred stock dividends     (75,000)   (75,000)
Net loss       (2,267,880) (2,267,880)
Balance at Jun. 30, 2023 $ 319,000 $ 133 111,521,965 (89,711,601) 22,129,497
Balance (in Shares) at Jun. 30, 2023 106,333 1,325,017      
Balance at Dec. 31, 2023 $ 319,000 $ 216 112,946,891 (100,160,891) 13,105,216
Balance (in Shares) at Dec. 31, 2023 106,333 2,150,412      
Stock based compensation expense     826,198   826,198
Shares issued as stock based compensation   $ 4 2,884   2,888
Shares issued as stock based compensation (in Shares)   46,200      
Common stock withheld to pay taxes (4,235) (4,235)
Common stock withheld to pay taxes (in Shares)   (3,025)      
Fees incurred in connection with equity offerings     (32,170)   (32,170)
Series C Preferred stock dividends     (150,000)   (150,000)
Net loss       (3,783,400) (3,783,400)
Balance at Jun. 30, 2024 $ 319,000 $ 220 113,589,568 (103,944,291) 9,964,497
Balance (in Shares) at Jun. 30, 2024 106,333 2,193,587      
Balance at Mar. 31, 2024 $ 319,000 $ 216 113,257,840 (101,905,434) 11,671,622
Balance (in Shares) at Mar. 31, 2024 106,333 2,150,412      
Stock based compensation expense     408,512   408,512
Shares issued as stock based compensation   $ 4 2,884   2,888
Shares issued as stock based compensation (in Shares)   46,200      
Common stock withheld to pay taxes (4,235) (4,235)
Common stock withheld to pay taxes (in Shares)   (3,025)      
Fees incurred in connection with equity offerings     (433)   (433)
Series C Preferred stock dividends     (75,000)   (75,000)
Net loss   (2,038,857) (2,038,857)
Balance at Jun. 30, 2024 $ 319,000 $ 220 $ 113,589,568 $ (103,944,291) $ 9,964,497
Balance (in Shares) at Jun. 30, 2024 106,333 2,193,587      
v3.24.2.u1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Statement of Cash Flows [Abstract]    
Net loss $ (3,783,400) $ (4,101,319)
Depreciation 56,859 50,803
Stock based compensation 829,086 794,503
Amortization of intangible assets 380,898 380,898
Amortization of product development costs 147,350
Amortization of software development costs 138,421
Loss on disposal of fixed assets 1,654
Deferred Revenue 25,069
Accounts receivable 1,729 386,186
Inventory 498,919 757,992
Prepaid expenses and other current assets (94,097) (251,173)
Accounts payable (281,725) (372,865)
Accrued expenses (539,366) (840,937)
Net Cash Used in Operating Activities (2,618,603) (3,195,912)
Cash flows from Investing Activities    
Purchase of equipment and website development (16,678) (48,697)
Product development costs (165,416) (400,630)
Software development costs (384,739) (90,050)
Net Cash Used in Investing Activities (566,833) (539,377)
Cash flows from Financing Activities    
Proceeds from the sale of common stock and warrants 5,211,428
Fees paid in connection with equity offerings (98,678) (816,017)
Common stock withheld to pay taxes (4,235)
Warrants exercised for common stock 162,494
Series C redeemable preferred stock dividends (150,000) (150,000)
Net Cash (Used in) Provided by Financing Activities (252,913) 4,407,905
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash (3,438,349) 672,616
Cash, Cash Equivalents and Restricted Cash - Beginning of Period 6,398,164 7,037,102
Cash, Cash Equivalents and Restricted Cash - End of Period 2,959,815 7,709,718
Non-cash investing and financing activities:    
Conversion of Series F preferred stock to common stock 201,000
Common stock issued to settle Series F preferred stock dividends 48,389
Fees in connection with deferred offering costs included in accounts payable and accrued expenses 153,113
Product development costs included in accounts payable and accrued expenses 81,033 130,027
Software development costs included in accounts payable and accrued expenses $ 91,656 $ 16,478
v3.24.2.u1
Organization And Principal Business Activities
6 Months Ended
Jun. 30, 2024
Organization And Principal Business Activities [Abstract]  
ORGANIZATION AND PRINCIPAL BUSINESS ACTIVITIES

NOTE 1 - ORGANIZATION AND PRINCIPAL BUSINESS ACTIVITIES

 

LogicMark, Inc. (“LogicMark” or the “Company”) was incorporated in the State of Delaware on February 8, 2012 and was reincorporated in the State of Nevada on June 1, 2023. LogicMark operates its business in one segment and provides personal emergency response systems (“PERS”), health communications devices, and Internet of Things technology that creates a connected care platform. The Company’s devices give people the ability to receive care at home and confidence to age independently. LogicMark revolutionized the PERS industry by incorporating two-way voice communication technology directly in the medical alert pendant and providing life-saving technology at a price point everyday consumers could afford. The PERS technologies as well as other personal safety devices are sold direct-to-consumer through the Company’s eCommerce website and Amazon.com, through dealers and distributors, as well as directly to the United States Veterans Health Administration (“VHA”).

v3.24.2.u1
Liquidity and Management Plans
6 Months Ended
Jun. 30, 2024
Liquidity and Management Plans [Abstract]  
LIQUIDITY AND MANAGEMENT PLANS

NOTE 2 - LIQUIDITY AND MANAGEMENT PLANS

 

The Company generated an operating loss of $3.9 million and a net loss of $3.8 million for the six months ended June 30, 2024. As of June 30, 2024, the Company had cash and cash equivalents of $3.0 million. As of June 30, 2024, the Company had working capital of $2.8 million and accumulated deficit of $103.9 million, compared to working capital and accumulated deficit as of December 31, 2023 of $6.0 million and $100.2 million, respectively.

 

Given the Company’s cash position as of June 30, 2024, and its projected cash flow from operations, the Company believes that it will have sufficient capital to sustain operations for a period of one year following the date of this filing. The Company may also raise funds through equity or debt offerings to accelerate the execution of its long-term strategic plan to develop and commercialize its core products and to fulfill its product development efforts. As further described in Note 9, Subsequent Event, on August 5, 2024, the Company closed a firm commitment public offering that resulted in gross proceeds to the Company of approximately $4.5 million.

v3.24.2.u1
Basis of Presentation
6 Months Ended
Jun. 30, 2024
Basis of Presentation [Abstract]  
BASIS OF PRESENTATION

NOTE 3 - BASIS OF PRESENTATION

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. In the opinion of management, the information herein reflects all adjustments, consisting only of normal recurring adjustments, except as otherwise noted, considered necessary for a fair statement of results of operations, financial position, stockholders’ equity, and cash flows. The results for the interim periods presented are not necessarily indicative of the results expected for any future period. The following information should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 which was filed with the SEC on April 16, 2024.

v3.24.2.u1
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

USE OF ESTIMATES IN THE CONDENSED FINANCIAL STATEMENTS

 

U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s management evaluates these significant estimates and assumptions, including those related to the fair value of acquired assets and liabilities, stock based compensation, income taxes, allowance for doubtful accounts, long-lived assets, and inventories, and other matters that affect the condensed financial statements and disclosures. Actual results could differ from those estimates.

 

CASH AND CASH EQUIVALENTS

 

The Company considers all highly liquid securities with an original maturity date of three months or less when purchased to be cash equivalents. Due to their short-term nature, cash equivalents are carried at cost, which approximates fair value. The Company had cash equivalents of $1.7 million and $4.7 million as of June 30, 2024 and December 31, 2023, respectively.

 

RESTRICTED CASH

 

Restricted cash includes amounts held as collateral for company credit cards. During the year ended December 31, 2023, the Company closed the company credit card and changed to a vendor that did not require cash collateral. As of June 30, 2024 and December 31, 2023, the Company did not have restricted cash.

 

CONCENTRATIONS OF CREDIT RISK

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains its cash and cash equivalents balances in large well-established financial institutions located in the United States. At times, the Company’s cash balances may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits.

 

REVENUE RECOGNITION

 

The Company’s revenues consist of product sales to either end customers, to distributors or direct bulk sales to the VHA. The Company’s revenues are derived from contracts with customers, which are in most cases customer purchase orders. For each contract, the promise to transfer the title of the products, each of which is individually distinct, is considered to be the identified performance obligation. As part of the consideration promised in each contract, the Company evaluates the customer’s credit risk. Our contracts do not have any financing components, as payments are mostly prepaid, or in limited cases, due net 30 days after the invoice date. The majority of prepaid contracts are with the VHA, which consists of the majority of the Company’s revenues. The Company’s products are almost always sold at fixed prices. In determining the transaction price, we evaluate whether the price is subject to any refunds, due to product returns or adjustments due to volume discounts, rebates, or price concessions to determine the net consideration we expect to be entitled to. The Company’s sales are recognized at a point-in-time under the core principle of recognizing revenue when title transfers to the customer, which generally occurs when the Company ships or delivers the product from its fulfillment center to our customers, when our customer accepts and has legal title of the goods, and the Company has a present right to payment for such goods. Based on the respective contract terms, most of our contract revenues are recognized either (i) upon shipment based on free on board (“FOB”) shipping point, or (ii) when the product arrives at its destination.

 

During the year ended December 31, 2023, the Company released new product and service offerings by leasing hardware coupled with monthly subscription services. The Company accounts for the revenue from its lease contracts by utilizing the single component accounting policy. This policy requires the Company to account for, by class of underlying asset, the lease component and non-lease component(s) associated with each lease as a single component if two criteria are met: (1) the timing and pattern of the lease component and the non-lease component are the same and (2) the lease component would be classified as an operating lease, if accounted for separately. The Company has determined that its leased hardware meets the criteria to be operating leases and has the same timing and pattern of transfer as its monthly subscription services. The Company has elected the lessor practical expedient within ASC 842, Leases (“ASC 842”) and recognizes, measures, presents, and discloses the revenue for the new offering based upon the predominant component, either the lease or non-lease component. The Company recognizes revenue under ASC 606, Revenue Recognition from Contracts with Customers (“ASC 606”) for its leased product for which it has estimated that the non-lease components of the new offering is the predominant component of the contract. For the three and six months ended June 30, 2024, the Company’s sales recognized over time were immaterial. For the three and six months ended June 30, 2023, none of the Company’s sales were recognized over time.

 

SALES TO DISTRIBUTORS AND RESELLERS

 

The Company maintains a reserve for unprocessed and estimated future price adjustments, claims and returns as a refund liability. The reserve is recorded as a reduction to revenue in the same period that the related revenue is recorded and is calculated based on an analysis of historical claims and returns over a period of time to appropriately account for current pricing and business trends. Similarly, sales returns and allowances are recorded based on historical return rates, as a reduction to revenue with a corresponding reduction to cost of goods sold for the estimated cost of inventory that is expected to be returned. These reserves were not material as of June 30, 2024 and December 31, 2023.

 

SHIPPING AND HANDLING

 

Amounts billed to customers for shipping and handling are included in revenues. The related freight charges incurred by the Company are included in cost of goods sold and were $0.1 million for the three and six months ended June 30, 2024, respectively, and $0.1 million and $0.2 million for the three and six months ended June 30, 2023.

 

ACCOUNTS RECEIVABLE - NET

 

For the three and six months ended June 30, 2024 and 2023, the Company’s revenues were primarily the result of shipments to VHA hospitals and clinics, which are made in most cases on a prepaid basis. The Company also sells its products to distributors and resellers, typically providing customers with modest trade credit terms. Sales made to distributors and resellers are done with limited rights of return and are subject to the normal warranties offered to the ultimate consumer for product defects.

 

Accounts receivable is stated at net realizable value. The Company regularly reviews accounts receivable balances and adjusts the accounts receivable allowance for credit losses, as necessary whenever events or circumstances indicate the carrying value may not be recoverable. As of June 30, 2024 and December 31, 2023, the allowance for credit losses was immaterial.

 

INVENTORY

 

The Company measures inventory at the lower of cost or net realizable value, defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Cost is determined using the first-in, first-out method.

 

The Company performs regular reviews of inventory quantities on hand and evaluates the realizable value of its inventories. The Company adjusts the carrying value of the inventory as necessary for excess, obsolete, and slow-moving inventory by comparing the individual inventory parts to forecasted product demand or production requirements. As of June 30, 2024, inventory was composed of $0.7 million in finished goods on hand. As of December 31, 2023, inventory was composed of $1.2 million in finished goods on hand.

 

The Company is required to partially prepay for inventory with certain vendors. As of June 30, 2024 and December 31, 2023, $0.4 million and $0.3 million, respectively, of prepayments were made for inventory in both periods and are included in prepaid expenses and other current assets on the balance sheet.

 

LONG-LIVED ASSETS

 

Long-lived assets, such as property and equipment, and other intangible assets are evaluated for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. When indicators exist, the Company tests for the impairment of the definite-lived assets based on the undiscounted future cash flow the assets are expected to generate over their remaining useful lives, compared to the carrying value of the assets. If the carrying amount of the assets is determined not to be recoverable, a write-down to fair value is recorded. Management estimates future cash flows using assumptions about expected future operating performance. Management’s estimates of future cash flows may differ from actual cash flow due to, among other things, technological changes, economic conditions, or changes to the Company’s business operations.

 

PROPERTY AND EQUIPMENT

 

Property and equipment consisting of equipment, furniture, fixtures, website and other is stated at cost. The costs of additions and improvements are generally capitalized and expenditures for repairs and maintenance are expensed in the period incurred. When items of property and equipment are sold or retired, the related costs and accumulated depreciation are removed from the accounts and any gain or loss is included in income. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful life of the respective asset as follows:

 

Equipment  5 years
Furniture and fixtures  3 to 5 years
Website and other  3 years

 

GOODWILL

 

Goodwill is reviewed annually in the fourth quarter, or when circumstances indicate that an impairment may have occurred. The Company first performs a qualitative assessment of goodwill impairment, which considers factors such as market conditions, performance compared to forecast, business outlook and unusual events. If the qualitative assessment indicates a possible goodwill impairment, goodwill is then quantitatively tested for impairment. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative test. If a quantitative goodwill impairment test is required, the fair value is determined using a variety of assumptions including estimated future cash flows using applicable discount rates (income approach), comparisons to other similar companies (market approach), and an adjusted balance sheet approach. As of June 30, 2024, no indicators of impairment were noted.

 

OTHER INTANGIBLE ASSETS

 

The Company’s intangible assets are related to the acquisition of LogicMark LLC in 2016, the former subsidiary that was merged with and into the Company and are included in other intangible assets in the Company’s condensed balance sheets as of June 30, 2024 and December 31, 2023.

 

As of June 30, 2024, the other intangible assets are composed of patents of $1.1 million; trademarks of $0.8 million; and customer relationships of $0.7 million. As of December 31, 2023, the other intangible assets are composed of patents of $1.3 million; trademarks of $0.8 million; and customer relationships of $0.8 million. The Company amortizes these intangible assets using the straight-line method over their estimated useful lives which for the patents, trademarks and customer relationships are 11 years, 20 years, and 10 years, respectively. During the three and six months ended June 30, 2024, the Company had amortization expense of $0.2 million and $0.4 million, respectively. During the three and six months ended June 30, 2023, the Company had amortization expense of $0.2 million and $0.4 million, respectively.

 

As of June 30, 2024, total amortization expense estimated for the remainder of fiscal year 2024 was $0.4 million. Amortization expense estimated for 2025 is expected to be approximately $0.8 million, $0.6 million for 2026, $0.3 million for 2027, $0.1 million for 2028, and approximately $0.4 million thereafter.

 

STOCK BASED COMPENSATION

 

The Company accounts for stock based awards exchanged for employee services at the estimated grant date fair value of the award. The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Stock based compensation charges are amortized over the vesting period or as earned. Stock based compensation is recorded in the same component of operating expenses as if it were paid in cash.

 

NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER SHARE

 

Basic net loss attributable to common stockholders per share (“Basic net loss per share”) was computed using the weighted average number of common shares outstanding. Diluted net loss applicable to common stockholders per share (“Diluted net loss per share”) includes the effect of diluted common stock equivalents. Potentially dilutive securities from the exercise of stock options to purchase 170,470 shares of common stock and warrants to purchase 9,284,290 shares of common stock as of June 30, 2024, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. Potentially dilutive securities from the exercise of stock options to purchase 35,928 shares of common stock and warrants to purchase 1,253,985 shares of common stock as of June 30, 2023, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive.

RESEARCH AND DEVELOPMENT AND PRODUCT AND SOFTWARE DEVELOPMENT COSTS

 

Research and development costs are expenditures on new market development and related engineering costs. In addition to internal resources, the Company utilizes functional consulting resources, third-party software, and hardware development firms. The Company expenses all research and development costs as incurred until technological feasibility has been established for the product. Once technological feasibility is established, development costs including software and hardware design are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. For the three months ended June 30, 2024, the Company capitalized $0.2 million and $0.2 million in product development costs and software development costs, respectively. For the six months ended June 30, 2024, the Company capitalized $0.3 million and $0.5 million in product development cost and software development costs, respectively. For the three and six months ended June 30, 2023, the Company capitalized $0.3 million and $0.5 million of such product development costs, respectively, and capitalized $0.1 million of such software development costs for both periods.  Amortization of these costs was on a straight-line basis over three years and amounted to approximately $73.9 thousand and $85.1 thousand for product development and software development, respectively, for the three months ended June 30, 2024. For the six months ended June 30, 2024, amortization of these costs amounted to approximately $147.4 thousand and $138.4 thousand for product development and software development, respectively. There was no amortization of product development costs during the three and six months ended June 30, 2023. Cumulatively, as of June 30, 2023, approximately $0.6 million of capitalized product development costs arose from expenditures to a company considered to be a related party since it is controlled by the Company’s Vice-President of Engineering.

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its financial statements and disclosures. 

 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which provides an update to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-07 will have a material impact on its financial statements and disclosures. 

v3.24.2.u1
Accrued Expenses
6 Months Ended
Jun. 30, 2024
Accrued Expenses [Abstract]  
ACCRUED EXPENSES

NOTE 5 - ACCRUED EXPENSES

 

Accrued expenses consist of the following:

 

   June 30,   December 31, 
   2024   2023 
Salaries, payroll taxes and vacation  $170,329   $167,930 
Merchant card fees   21,500    14,983 
Professional fees   101,920    83,532 
Management incentives   203,431    503,800 
Lease liability   74,116    68,321 
Development costs   70,000    109,000 
Other   126,421    203,632 
Totals  $767,717   $1,151,198 
v3.24.2.u1
Stockholders’ Equity and Redeemable Preferred Stock
6 Months Ended
Jun. 30, 2024
Stockholders’ Equity and Redeemable Preferred Stock [Abstract]  
STOCKHOLDERS’ EQUITY AND REDEEMABLE PREFERRED STOCK

NOTE 6 - STOCKHOLDERS’ EQUITY AND REDEEMABLE PREFERRED STOCK

 

November 2023 Warrant Inducement Transactions

 

On November 21, 2023, the Company entered into inducement agreements (together, the “Inducement Agreements”) with certain of its warrant holders, pursuant to which the Company induced such warrant holders to exercise for cash their common stock purchase warrants issued pursuant to firm commitment public offerings by the Company that closed on September 15, 2021 (the “Existing September 2021 Warrants”) and January 25, 2023 (the “Existing January 2023 Warrants” and together with the Existing September 2021 Warrants, the “Existing Warrants”) to purchase up to approximately 909,059 shares of Common Stock, at a lower exercise price of (x) $2.00 per share for the Existing September 2021 Warrants and (y) $2.00 per one and one-half share for the Existing January 2023 Warrants, during the period from the date of the Inducement Agreements until December 20, 2023 (the “Inducement Deadline”). In consideration for the warrant holders’ agreement to exercise the Existing Warrants in accordance with the Inducement Agreements, the Company agreed to issue such warrant holders the Warrants as follows: (A) Series A Common Stock purchase warrants (the “Series A Warrants”) to purchase up to a number of shares of Common Stock equal to 200% of the number of shares of Common Stock issued upon exercise of the Existing September 2021 Warrants (up to 80,732 shares) (the “Series A Warrant Shares”), at an exercise price of $2.00 per Series A Warrant Share; and (B) Series B Common Stock purchase warrants (the “Series B Warrants”) to purchase up to a number of shares of Common Stock equal to 200% of the number of shares of Common Stock issued upon exercise of the Existing January 2023 Warrants (up to 1,382,058 shares) (the “Series B Warrant Shares”), at an exercise price of $2.00 per one and one-half Series B Warrant Share. Of the Series A Warrants, 50% are immediately exercisable and expire on the Termination Date (as defined in the Existing September 2021 Warrants) and 50% are exercisable at any time on or after the Stockholder Approval Date (as defined in the Inducement Agreements), and have a term of exercise of five and a half years from the date of the initial closing of the transactions contemplated by the Inducement Agreements. Of the Series B Warrants, 50% are immediately exercisable and expire on the Termination Date (as defined in the Existing January 2023 Warrants) and 50% are exercisable at any time on or after the Stockholder Approval Date, and have a term of exercise of five and a half years from the date of the initial closing of the transactions contemplated by the Inducement Agreements. The Company used the proceeds from the exercise of the Existing Warrants for working capital purposes and other general corporate purposes. On May 22, 2024, the November 2023 Warrant Inducement was approved by stockholders at the Annual Meeting of Stockholders.

January 2023 Offering

 

On January 25, 2023, the Company closed a firm commitment registered public offering (the “January Offering”) pursuant to which the Company issued (i) 529,250 shares of Common Stock and 10,585,000 common stock purchase warrants (exercisable for 793,875 shares of Common Stock at a purchase price of $2.52 per share), subject to certain adjustments and (ii) 3,440,000 pre-funded common stock purchase warrants that were exercised for 172,000 shares of Common Stock at a purchase price of $0.02 per share, subject to certain adjustments and 3,440,000 warrants to purchase up to an aggregate of 258,000 shares of Common Stock at a purchase price of $2.52 per share and (iii) 815,198 additional warrants to purchase up to 61,140 shares of Common Stock at a purchase price of $2.52 per share, which additional warrants were issued upon the partial exercise by the underwriters of their over-allotment option, pursuant to an underwriting agreement, dated as of January 23, 2023 between the Company and Maxim Group LLC, as representative of the underwriters. The January Offering resulted in gross proceeds to the Company of approximately $5.2 million, before deducting underwriting discounts and commissions of 7% of the gross proceeds (3.5% of the gross proceeds in the case of certain identified investors) and estimated January Offering expenses.

 

Series C Redeemable Preferred Stock

 

In May 2017, the Company authorized Series C Redeemable Preferred Stock. Holders of Series C Redeemable Preferred Stock are entitled to receive dividends of 15% per year, payable in cash. For each of the three and six months ended June 30, 2024 and June 30, 2023, the Company recorded Series C Redeemable Preferred Stock dividends of $75 thousand and $150 thousand, respectively.

 

The Series C Redeemable Preferred Stock may be redeemed by the Company at the Company’s option in cash at any time, in whole or in part, upon payment of the stated value of the Series C Redeemable Preferred Stock and unpaid dividends. If a “fundamental change” occurs, the Series C Redeemable Preferred Stock shall be immediately redeemed in cash equal to the stated value of the Series C Redeemable Preferred Stock, and unpaid dividends. A fundamental change includes but is not limited to any change in the ownership of at least fifty percent of the voting stock; liquidation or dissolution; or the common stock ceases to be listed on the market upon which it currently trades.

 

The holders of the Series C Redeemable Preferred Stock are entitled to vote on any matter submitted to the stockholders of the Company for a vote. One share of Series C Redeemable Preferred Stock carries the same voting rights as one share of common stock.

 

A redeemable equity security is to be classified as temporary equity if it is conditionally redeemable upon the occurrence of an event that is not solely within the control of the issuer. Upon the determination that such events are probable, the equity security would be classified as a liability. Given the Series C Redeemable Preferred Stock contains a fundamental change provision, the security is considered conditionally redeemable. Therefore, the Company has classified the Series C Redeemable Preferred Stock as temporary equity in the balance sheets as of June 30, 2024 and December 31, 2023 until such time that events occur that indicate otherwise.

 

Warrants

 

The following table summarizes the Company’s warrants outstanding and exercisable as of June 30, 2024 and December 31, 2023:

 

           Weighted     
       Weighted   Average     
       Average   Remaining   Aggregate 
   Number of   Exercise   Life   Intrinsic 
   Warrants   Price   In Years   Value 
                 
Outstanding and Exercisable at January 1, 2024   9,531,242   $39.44    3.72   $
          -
 
Expired warrants   (246,952)  $305.00    
 
    
 
 
Outstanding and Exercisable at June 30, 2024   9,284,290   $33.09    3.24   $
-
 
v3.24.2.u1
Stock Incentive Plans
6 Months Ended
Jun. 30, 2024
Stock Incentive Plans [Abstract]  
STOCK INCENTIVE PLANS

NOTE 7 - STOCK INCENTIVE PLANS

 

2023 Stock Incentive Plan

 

On March 7, 2023, the Company’s stockholders approved the 2023 Stock Incentive Plan (“2023 Plan”). The aggregate maximum number of shares of common stock that may be issued under the 2023 Plan is 68,723 shares for the 2023 fiscal year; thereafter, the maximum number is limited to 15% of the outstanding shares of common stock, calculated on the first business day of each fiscal quarter. As of June 30, 2024, the maximum number of shares of common stock that may be issued under the 2023 Plan is 322,562. Under the 2023 Plan, options which are forfeited or terminated, settled in cash in lieu of shares of common stock, or settled in a manner such that shares are not issued, will again immediately become available to be issued. If shares of common stock are withheld from payment of an award to satisfy tax obligations with respect to the award, those shares of common stock will be treated as shares that have been issued under the 2023 Plan and will not again be available for issuance.

 

During the three and six months ended June 30, 2024, the Company issued an aggregate of 1,375 stock options under the Company’s 2023 Stock Incentive Plan (the “2023 Plan”), vesting over a period of four years to employees with an exercise price of $1.06 per share and 625 stock options under the 2023 Plan, vesting over a period of four years to employees with an exercise price of $1.00 per share in consideration for services provided to the Company. In addition, an aggregate of 42,138 fully vested stock options were granted under the 2023 Plan to five non-employee directors at an exercise price of $1.06 per share, an aggregate of 16,854 fully vested stock options were granted under the 2023 Plan to three non-employee directors at an exercise price of $1.73 per share and an aggregate of 40,000 fully vested stock options were granted under the 2023 Plan to four non-employee directors at an exercise price of $1.00 per share in each case in consideration for services provided to the Company. The aggregate fair value of the shares issued to the directors was $85.4 thousand. As of June 30, 2024, the unrecognized compensation cost related to non-vested stock options was $26.4 thousand. 

 

During the three and six months ended June 30, 2024, 1,125 stock options were forfeited by participants under the 2023 Plan.

 

During the three and six months ended June 30, 2023, no stock options were forfeited by participants under the 2023 Plan.

 

2017 Stock Incentive Plan

 

On August 24, 2017, the Company’s stockholders approved the 2017 Stock Incentive Plan (“2017 SIP”). The aggregate maximum number of shares of common stock that may be issued under the 2017 SIP is limited to 10% of the outstanding shares of common stock, calculated on the first business day of each fiscal year. Under the 2017 SIP, options which are forfeited or terminated, settled in cash in lieu of shares of common stock, or settled in a manner such that shares are not issued, will again immediately become available to be issued. If shares of common stock are withheld from payment of an award to satisfy tax obligations with respect to the award, those shares of common stock will be treated as shares that have been issued under the 2017 SIP and will not again be available for issuance. On March 7, 2023, the Company’s 2017 SIP was terminated upon the approval of the 2023 Plan at the Company’s special meeting of stockholders.

 

During the three and six months ended June 30, 2024, the Company did not issue any stock options under the 2017 SIP. As of June 30, 2024, the unrecognized compensation cost related to non-vested stock options was $17.9 thousand.

 

During the three months ended June 30, 2023, the Company did not issue any stock options. During the six months ended June 30, 2023, the Company issued 3,125 stock options vesting over four years to employees with an exercise price of $3.80 per share and a total aggregate fair value of $11 thousand. In addition, 10,528 fully vested stock options were granted to four non-employee Board directors at an exercise price of $3.80 per share. The aggregate fair value of the shares issued to the directors was $35 thousand.

 

During the six months ended June 30, 2024, 1,000 stock options were forfeited by participants under the 2017 SIP. During the three and six months ended June 30, 2023, 125 and 750 stock options were forfeited, respectively, by participants under the 2017 SIP. 

 

2013 Long-Term Stock Incentive Plan

 

On January 4, 2013, the Company’s stockholders approved the Company’s Long-Term Stock Incentive Plan (“2013 LTIP”). The maximum number of shares of common stock that may be issued under the 2013 LTIP, including stock awards, stock issued to the Company’s Board, and stock appreciation rights, is limited to 10% of the common shares outstanding on the first business day of any fiscal year. The Company’s 2013 LTIP expired in accordance with its terms on January 3, 2023.

 

During the three and six months ended June 30, 2024 and 2023, the Company did not issue any stock options under the 2013 LTIP. As of June 30, 2024, the unrecognized compensation cost related to non-vested stock options was $0.2 million.

 

During the three and six months ended June 30, 2024, no stock options were forfeited by participants under the 2013 LTIP. During the three months ended June 30, 2023, no stock options were forfeited and during the six months ended June 30, 2023, 1,250 stock options were forfeited by participants under the 2013 LTIP.

 

Stock based Compensation Expense 

 

Total stock based compensation expense during the three and six months ended June 30, 2024 pertaining to awards under the 2023 Plan, the 2017 SIP and the 2013 LTIP amounted to $0.4 million and $0.8 million, respectively. Total stock based compensation expense during the three and six months ended June 30, 2023, pertaining to awards under the 2017 SIP and 2013 LTIP amounted to $0.4 million and $0.8 million, respectively.

v3.24.2.u1
Commitments and Contingencies
6 Months Ended
Jun. 30, 2024
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 8 - COMMITMENTS AND CONTINGENCIES

 

LEGAL MATTERS

 

From time to time, the Company may be involved in various claims and legal actions arising in the ordinary course of our business. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company or any of our subsidiaries, threatened against or affecting our company, or any of our subsidiaries in which an adverse decision could have a material adverse effect upon our business, operating results, or financial condition.

 

COMMITMENTS

 

The Company leases warehouse space and equipment, in the U.S., which is classified as operating leases expiring at various dates. The Company determines if an arrangement qualifies as a lease at the lease inception. Operating lease liabilities are recorded based on the present value of the future lease payments over the lease term, assessed as of the commencement date. The Company’s real estate lease is for a fulfillment center, with a lease term of 5 years expiring in August 2025. The Company has elected to account for the lease and non-lease components (insurance and property taxes) as a single lease component for its real estate leases. Lease payments, which includes lease components and non-lease components, are included in the measurement of the Company’s lease liabilities to the extent that such payments are either fixed amounts or variable amounts based on a rate or index (fixed in substance) as stipulated in the lease contract. Any actual costs in excess of such amounts are expensed as incurred as variable lease cost.

 

The Company’s lease agreements generally do not specify an implicit borrowing rate, and as such, the Company uses its incremental borrowing rate to calculate the present value of the future lease payments. The discount rate represents a risk-adjusted rate on a secured basis and is the rate at which the Company would borrow funds to satisfy the scheduled lease liability payment streams. The Company entered into a new five-year lease agreement in June 2020 for new warehouse space located in Louisville, Kentucky. The Right of Use (“ROU”) asset value added as a result of this new lease agreement was $0.3 million. The Company’s ROU asset and lease liability accounts reflect the inclusion of this lease in the Company’s balance sheets as of June 30, 2024 and December 31, 2023. The current monthly rent of $6.6 thousand increased from the commencement amount of $6.4 thousand in September 2023 in accordance with the lease agreement, which requires that the rent increase 3% annually.

 

The Company’s lease agreements include options for the Company to either renew or early terminate the lease. Renewal options are reviewed at lease commencement to determine if such options are reasonably certain of being exercised, which could impact the lease term. When determining if a renewal option is reasonably certain of being exercised, the Company considers several factors, including significance of leasehold improvements on the property, whether the asset is difficult to replace, or specific characteristics unique to the lease that would make it reasonably certain that the Company would exercise the option. In most cases, the Company has concluded that renewal and early termination options are not reasonably certain of being exercised by the Company and thus not included in the Company’s ROU asset and lease liability.

 

For the three and six months ended June 30, 2024, total operating lease cost was $19.2 thousand and $38.5 thousand, respectively, and was recorded in direct operating costs. Operating lease cost for the three and six months ended June 30, 2023 amounted to $25.2 thousand and $50.7 thousand and was recorded in direct operating costs and general and administrative expenses. Operating lease cost is recognized on a straight-line basis over the lease term. The following summarizes (i) the future minimum undiscounted lease payments under the non-cancelable lease for each of the next three years and thereafter, incorporating the practical expedient to account for lease and non-lease components as a single lease component for our existing real estate lease, (ii) a reconciliation of the undiscounted lease payments to the present value of the lease liabilities, and (iii) the lease-related account balances on the Company’s balance sheet as of June 30, 2024:

 

Year Ending December 31,    
2024 (for the remainder of 2024)   40,400 
2025   54,400 
Total future minimum lease payments  $94,800 
Less imputed interest   (7,302)
Total present value of future minimum lease payments  $87,498 

 

As of June 30, 2024    
Operating lease right-of-use assets  $82,298 
      
Accrued expenses  $74,116 
Other long-term liabilities   13,382 
   $87,498 

 

As of June 30, 2024    
Weighted Average Remaining Lease Term   1.17 
Weighted Average Discount Rate   13.00%
v3.24.2.u1
Subsequent Event
6 Months Ended
Jun. 30, 2024
Subsequent Event [Abstract]  
SUBSEQUENT EVENT

NOTE 9 – SUBSEQUENT EVENT

 

Best Efforts Public Offering

 

On August 5, 2024 (the “Closing Date”), the Company, in connection with a best efforts public offering (the “Offering”), sold to certain purchasers an aggregate of (x) 1,449,916 units of the Company (the “Units”) at an offering price of $0.4654 per Unit, consisting of (i) 1,449,916 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”) (ii) 1,449,916 of the Company’s Series A warrants to purchase Common Stock, exercisable for up to 1,449,916 shares of Common Stock (the “August Series A Warrants”), and (iii) 1,449,916 of the Company’s Series B warrants to purchase Common Stock, exercisable for up to 1,449,916 shares of Common Stock (the “August Series B Warrants”); and (y) 8,220,084 pre-funded units of the Company (the “Pre-Funded Units”) at an offering price $0.4644 per Pre-Funded Unit, consisting of (i) 8,220,084 pre-funded common stock purchase warrants exercisable for up to 8,220,084 shares of Common Stock at $0.001 per share, (the “August Pre-Funded Warrants”), (ii) 8,220,084 August Series A Warrants and (iii) 8,220,084 August Series B Warrants, pursuant to the Company’s Form S-1 registration statement, as amended (File No. 333-279133), declared effective by the SEC on August 1, 2024 and securities purchase agreements, dated August 2, 2024, between the Company and each of the purchasers signatory thereto (the “Purchasers”). On the Closing Date, the Company received gross proceeds of approximately $4.5 million, before deducting placement agent discounts and commissions and estimated Offering expenses. The Company intends to use the net proceeds from the Offering for continued new product development, working capital and other general corporate purposes.

 

In addition, as of August 12, 2024, the Purchasers exercised their August Pre-Funded Warrants for an aggregate of 2,421,930 shares of Common Stock.

v3.24.2.u1
Pay vs Performance Disclosure - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Pay vs Performance Disclosure        
Net Income (Loss) $ (2,038,857) $ (2,267,880) $ (3,783,400) $ (4,101,319)
v3.24.2.u1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.2.u1
Accounting Policies, by Policy (Policies)
6 Months Ended
Jun. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
USE OF ESTIMATES IN THE CONDENSED FINANCIAL STATEMENTS

USE OF ESTIMATES IN THE CONDENSED FINANCIAL STATEMENTS

U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s management evaluates these significant estimates and assumptions, including those related to the fair value of acquired assets and liabilities, stock based compensation, income taxes, allowance for doubtful accounts, long-lived assets, and inventories, and other matters that affect the condensed financial statements and disclosures. Actual results could differ from those estimates.

CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS

The Company considers all highly liquid securities with an original maturity date of three months or less when purchased to be cash equivalents. Due to their short-term nature, cash equivalents are carried at cost, which approximates fair value. The Company had cash equivalents of $1.7 million and $4.7 million as of June 30, 2024 and December 31, 2023, respectively.

RESTRICTED CASH

RESTRICTED CASH

Restricted cash includes amounts held as collateral for company credit cards. During the year ended December 31, 2023, the Company closed the company credit card and changed to a vendor that did not require cash collateral. As of June 30, 2024 and December 31, 2023, the Company did not have restricted cash.

CONCENTRATIONS OF CREDIT RISK

CONCENTRATIONS OF CREDIT RISK

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains its cash and cash equivalents balances in large well-established financial institutions located in the United States. At times, the Company’s cash balances may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits.

 

REVENUE RECOGNITION

REVENUE RECOGNITION

The Company’s revenues consist of product sales to either end customers, to distributors or direct bulk sales to the VHA. The Company’s revenues are derived from contracts with customers, which are in most cases customer purchase orders. For each contract, the promise to transfer the title of the products, each of which is individually distinct, is considered to be the identified performance obligation. As part of the consideration promised in each contract, the Company evaluates the customer’s credit risk. Our contracts do not have any financing components, as payments are mostly prepaid, or in limited cases, due net 30 days after the invoice date. The majority of prepaid contracts are with the VHA, which consists of the majority of the Company’s revenues. The Company’s products are almost always sold at fixed prices. In determining the transaction price, we evaluate whether the price is subject to any refunds, due to product returns or adjustments due to volume discounts, rebates, or price concessions to determine the net consideration we expect to be entitled to. The Company’s sales are recognized at a point-in-time under the core principle of recognizing revenue when title transfers to the customer, which generally occurs when the Company ships or delivers the product from its fulfillment center to our customers, when our customer accepts and has legal title of the goods, and the Company has a present right to payment for such goods. Based on the respective contract terms, most of our contract revenues are recognized either (i) upon shipment based on free on board (“FOB”) shipping point, or (ii) when the product arrives at its destination.

During the year ended December 31, 2023, the Company released new product and service offerings by leasing hardware coupled with monthly subscription services. The Company accounts for the revenue from its lease contracts by utilizing the single component accounting policy. This policy requires the Company to account for, by class of underlying asset, the lease component and non-lease component(s) associated with each lease as a single component if two criteria are met: (1) the timing and pattern of the lease component and the non-lease component are the same and (2) the lease component would be classified as an operating lease, if accounted for separately. The Company has determined that its leased hardware meets the criteria to be operating leases and has the same timing and pattern of transfer as its monthly subscription services. The Company has elected the lessor practical expedient within ASC 842, Leases (“ASC 842”) and recognizes, measures, presents, and discloses the revenue for the new offering based upon the predominant component, either the lease or non-lease component. The Company recognizes revenue under ASC 606, Revenue Recognition from Contracts with Customers (“ASC 606”) for its leased product for which it has estimated that the non-lease components of the new offering is the predominant component of the contract. For the three and six months ended June 30, 2024, the Company’s sales recognized over time were immaterial. For the three and six months ended June 30, 2023, none of the Company’s sales were recognized over time.

SALES TO DISTRIBUTORS AND RESELLERS

SALES TO DISTRIBUTORS AND RESELLERS

The Company maintains a reserve for unprocessed and estimated future price adjustments, claims and returns as a refund liability. The reserve is recorded as a reduction to revenue in the same period that the related revenue is recorded and is calculated based on an analysis of historical claims and returns over a period of time to appropriately account for current pricing and business trends. Similarly, sales returns and allowances are recorded based on historical return rates, as a reduction to revenue with a corresponding reduction to cost of goods sold for the estimated cost of inventory that is expected to be returned. These reserves were not material as of June 30, 2024 and December 31, 2023.

SHIPPING AND HANDLING

SHIPPING AND HANDLING

Amounts billed to customers for shipping and handling are included in revenues. The related freight charges incurred by the Company are included in cost of goods sold and were $0.1 million for the three and six months ended June 30, 2024, respectively, and $0.1 million and $0.2 million for the three and six months ended June 30, 2023.

 

ACCOUNTS RECEIVABLE - NET

ACCOUNTS RECEIVABLE - NET

For the three and six months ended June 30, 2024 and 2023, the Company’s revenues were primarily the result of shipments to VHA hospitals and clinics, which are made in most cases on a prepaid basis. The Company also sells its products to distributors and resellers, typically providing customers with modest trade credit terms. Sales made to distributors and resellers are done with limited rights of return and are subject to the normal warranties offered to the ultimate consumer for product defects.

Accounts receivable is stated at net realizable value. The Company regularly reviews accounts receivable balances and adjusts the accounts receivable allowance for credit losses, as necessary whenever events or circumstances indicate the carrying value may not be recoverable. As of June 30, 2024 and December 31, 2023, the allowance for credit losses was immaterial.

INVENTORY

INVENTORY

The Company measures inventory at the lower of cost or net realizable value, defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Cost is determined using the first-in, first-out method.

The Company performs regular reviews of inventory quantities on hand and evaluates the realizable value of its inventories. The Company adjusts the carrying value of the inventory as necessary for excess, obsolete, and slow-moving inventory by comparing the individual inventory parts to forecasted product demand or production requirements. As of June 30, 2024, inventory was composed of $0.7 million in finished goods on hand. As of December 31, 2023, inventory was composed of $1.2 million in finished goods on hand.

The Company is required to partially prepay for inventory with certain vendors. As of June 30, 2024 and December 31, 2023, $0.4 million and $0.3 million, respectively, of prepayments were made for inventory in both periods and are included in prepaid expenses and other current assets on the balance sheet.

LONG-LIVED ASSETS

LONG-LIVED ASSETS

Long-lived assets, such as property and equipment, and other intangible assets are evaluated for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. When indicators exist, the Company tests for the impairment of the definite-lived assets based on the undiscounted future cash flow the assets are expected to generate over their remaining useful lives, compared to the carrying value of the assets. If the carrying amount of the assets is determined not to be recoverable, a write-down to fair value is recorded. Management estimates future cash flows using assumptions about expected future operating performance. Management’s estimates of future cash flows may differ from actual cash flow due to, among other things, technological changes, economic conditions, or changes to the Company’s business operations.

 

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT

Property and equipment consisting of equipment, furniture, fixtures, website and other is stated at cost. The costs of additions and improvements are generally capitalized and expenditures for repairs and maintenance are expensed in the period incurred. When items of property and equipment are sold or retired, the related costs and accumulated depreciation are removed from the accounts and any gain or loss is included in income. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful life of the respective asset as follows:

Equipment  5 years
Furniture and fixtures  3 to 5 years
Website and other  3 years
GOODWILL

GOODWILL

Goodwill is reviewed annually in the fourth quarter, or when circumstances indicate that an impairment may have occurred. The Company first performs a qualitative assessment of goodwill impairment, which considers factors such as market conditions, performance compared to forecast, business outlook and unusual events. If the qualitative assessment indicates a possible goodwill impairment, goodwill is then quantitatively tested for impairment. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative test. If a quantitative goodwill impairment test is required, the fair value is determined using a variety of assumptions including estimated future cash flows using applicable discount rates (income approach), comparisons to other similar companies (market approach), and an adjusted balance sheet approach. As of June 30, 2024, no indicators of impairment were noted.

OTHER INTANGIBLE ASSETS

OTHER INTANGIBLE ASSETS

The Company’s intangible assets are related to the acquisition of LogicMark LLC in 2016, the former subsidiary that was merged with and into the Company and are included in other intangible assets in the Company’s condensed balance sheets as of June 30, 2024 and December 31, 2023.

As of June 30, 2024, the other intangible assets are composed of patents of $1.1 million; trademarks of $0.8 million; and customer relationships of $0.7 million. As of December 31, 2023, the other intangible assets are composed of patents of $1.3 million; trademarks of $0.8 million; and customer relationships of $0.8 million. The Company amortizes these intangible assets using the straight-line method over their estimated useful lives which for the patents, trademarks and customer relationships are 11 years, 20 years, and 10 years, respectively. During the three and six months ended June 30, 2024, the Company had amortization expense of $0.2 million and $0.4 million, respectively. During the three and six months ended June 30, 2023, the Company had amortization expense of $0.2 million and $0.4 million, respectively.

As of June 30, 2024, total amortization expense estimated for the remainder of fiscal year 2024 was $0.4 million. Amortization expense estimated for 2025 is expected to be approximately $0.8 million, $0.6 million for 2026, $0.3 million for 2027, $0.1 million for 2028, and approximately $0.4 million thereafter.

STOCK BASED COMPENSATION

STOCK BASED COMPENSATION

The Company accounts for stock based awards exchanged for employee services at the estimated grant date fair value of the award. The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Stock based compensation charges are amortized over the vesting period or as earned. Stock based compensation is recorded in the same component of operating expenses as if it were paid in cash.

NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER SHARE

NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER SHARE

Basic net loss attributable to common stockholders per share (“Basic net loss per share”) was computed using the weighted average number of common shares outstanding. Diluted net loss applicable to common stockholders per share (“Diluted net loss per share”) includes the effect of diluted common stock equivalents. Potentially dilutive securities from the exercise of stock options to purchase 170,470 shares of common stock and warrants to purchase 9,284,290 shares of common stock as of June 30, 2024, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. Potentially dilutive securities from the exercise of stock options to purchase 35,928 shares of common stock and warrants to purchase 1,253,985 shares of common stock as of June 30, 2023, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive.

RESEARCH AND DEVELOPMENT AND PRODUCT AND SOFTWARE DEVELOPMENT COSTS

RESEARCH AND DEVELOPMENT AND PRODUCT AND SOFTWARE DEVELOPMENT COSTS

Research and development costs are expenditures on new market development and related engineering costs. In addition to internal resources, the Company utilizes functional consulting resources, third-party software, and hardware development firms. The Company expenses all research and development costs as incurred until technological feasibility has been established for the product. Once technological feasibility is established, development costs including software and hardware design are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. For the three months ended June 30, 2024, the Company capitalized $0.2 million and $0.2 million in product development costs and software development costs, respectively. For the six months ended June 30, 2024, the Company capitalized $0.3 million and $0.5 million in product development cost and software development costs, respectively. For the three and six months ended June 30, 2023, the Company capitalized $0.3 million and $0.5 million of such product development costs, respectively, and capitalized $0.1 million of such software development costs for both periods.  Amortization of these costs was on a straight-line basis over three years and amounted to approximately $73.9 thousand and $85.1 thousand for product development and software development, respectively, for the three months ended June 30, 2024. For the six months ended June 30, 2024, amortization of these costs amounted to approximately $147.4 thousand and $138.4 thousand for product development and software development, respectively. There was no amortization of product development costs during the three and six months ended June 30, 2023. Cumulatively, as of June 30, 2023, approximately $0.6 million of capitalized product development costs arose from expenditures to a company considered to be a related party since it is controlled by the Company’s Vice-President of Engineering.

RECENT ACCOUNTING PRONOUNCEMENTS

RECENT ACCOUNTING PRONOUNCEMENTS

In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which requires disclosure of incremental income tax information within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-09 will have a material impact on its financial statements and disclosures. 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which provides an update to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company’s management does not believe the adoption of ASU 2023-07 will have a material impact on its financial statements and disclosures. 

v3.24.2.u1
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
Schedule of Property and Equipment Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful life of the respective asset as follows:
Equipment  5 years
Furniture and fixtures  3 to 5 years
Website and other  3 years
v3.24.2.u1
Accrued Expenses (Tables)
6 Months Ended
Jun. 30, 2024
Accrued Expenses [Abstract]  
Schedule of Accrued Expenses Accrued expenses consist of the following:
   June 30,   December 31, 
   2024   2023 
Salaries, payroll taxes and vacation  $170,329   $167,930 
Merchant card fees   21,500    14,983 
Professional fees   101,920    83,532 
Management incentives   203,431    503,800 
Lease liability   74,116    68,321 
Development costs   70,000    109,000 
Other   126,421    203,632 
Totals  $767,717   $1,151,198 
v3.24.2.u1
Stockholders’ Equity and Redeemable Preferred Stock (Tables)
6 Months Ended
Jun. 30, 2024
Stockholders’ Equity and Redeemable Preferred Stock [Abstract]  
Schedule of Warrants Outstanding and Exercisable The following table summarizes the Company’s warrants outstanding and exercisable as of June 30, 2024 and December 31, 2023:
           Weighted     
       Weighted   Average     
       Average   Remaining   Aggregate 
   Number of   Exercise   Life   Intrinsic 
   Warrants   Price   In Years   Value 
                 
Outstanding and Exercisable at January 1, 2024   9,531,242   $39.44    3.72   $
          -
 
Expired warrants   (246,952)  $305.00    
 
    
 
 
Outstanding and Exercisable at June 30, 2024   9,284,290   $33.09    3.24   $
-
 
v3.24.2.u1
Commitments and Contingencies (Tables)
6 Months Ended
Jun. 30, 2024
Commitments and Contingencies [Abstract]  
Schedule of Future Minimum Lease Payments the lease-related account balances on the Company’s balance sheet as of June 30, 2024:
Year Ending December 31,    
2024 (for the remainder of 2024)   40,400 
2025   54,400 
Total future minimum lease payments  $94,800 
Less imputed interest   (7,302)
Total present value of future minimum lease payments  $87,498 
Schedule of Lease Expense
As of June 30, 2024    
Operating lease right-of-use assets  $82,298 
      
Accrued expenses  $74,116 
Other long-term liabilities   13,382 
   $87,498 
As of June 30, 2024    
Weighted Average Remaining Lease Term   1.17 
Weighted Average Discount Rate   13.00%
v3.24.2.u1
Liquidity and Management Plans (Details) - USD ($)
3 Months Ended 6 Months Ended
Aug. 05, 2024
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Liquidity and Management Plans (Details) [Line Items]            
Operating loss   $ (2,070,882) $ (2,276,390) $ (3,876,577) $ (4,162,257)  
Net loss   (2,038,857) $ (2,267,880) (3,783,400) $ (4,101,319)  
Cash and cash equivalents   2,959,815   2,959,815   $ 6,398,164
Working capital   2,800,000   2,800,000   6,000,000
Accumulated deficit   $ (103,944,291)   $ (103,944,291)   $ (100,160,891)
Subsequent Event [Member]            
Liquidity and Management Plans (Details) [Line Items]            
Gross proceeds $ 4,500,000          
v3.24.2.u1
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Summary of Significant Accounting Policies [Line Items]          
Cash equivalents $ 1,700,000   $ 1,700,000   $ 4,700,000
Cost of goods sold 100,000 $ 100,000 100,000 $ 200,000  
Inventory finished goods 700,000   700,000   1,200,000
Prepaid expenses 400,000   400,000   300,000
Other Depreciation and Amortization 200,000 200,000 400,000 $ 400,000  
Amortization expense 400,000   400,000    
Amortization expense estimated of thereafter 400,000   $ 400,000    
Stock options purchase (in Shares)     170,470 35,928  
Development cost 200,000 500,000 $ 300,000    
Software development costs 200,000   500,000    
Capitalized costs 100,000 $ 300,000 100,000 $ 300,000  
Amortization costs     138,400    
Software Development [Member]          
Summary of Significant Accounting Policies [Line Items]          
Amortization costs 73,900   147,400    
Software and Software Development Costs [Member]          
Summary of Significant Accounting Policies [Line Items]          
Amortization costs 85,100        
Logic Mark [Member] | Customer Relationships [Member]          
Summary of Significant Accounting Policies [Line Items]          
Intangible assets of patents 1,100,000   1,100,000    
Intangible assets customer relationships         $ 800,000
Other intangible assets, estimated useful lives         10 years
Logic Mark [Member] | Patents [Member]          
Summary of Significant Accounting Policies [Line Items]          
Intangible assets of patents         $ 1,300,000
Intangible assets trademarks 800,000   800,000    
Other intangible assets, estimated useful lives         11 years
Logic Mark [Member] | Trademarks [Member]          
Summary of Significant Accounting Policies [Line Items]          
Intangible assets trademarks         $ 800,000
Intangible assets customer relationships $ 700,000   $ 700,000    
Other intangible assets, estimated useful lives         20 years
Related Party [Member]          
Summary of Significant Accounting Policies [Line Items]          
Development cost       $ 600,000  
Warrant [Member]          
Summary of Significant Accounting Policies [Line Items]          
Purchase of warrant shares (in Shares) 9,284,290 1,253,985 9,284,290 1,253,985  
2025 [Member]          
Summary of Significant Accounting Policies [Line Items]          
Amortization expense estimated $ 800,000   $ 800,000    
2026 [Member]          
Summary of Significant Accounting Policies [Line Items]          
Amortization expense estimated 600,000   600,000    
2027 [Member]          
Summary of Significant Accounting Policies [Line Items]          
Amortization expense estimated 300,000   300,000    
2028 [Member]          
Summary of Significant Accounting Policies [Line Items]          
Amortization expense estimated $ 100,000   $ 100,000    
v3.24.2.u1
Summary of Significant Accounting Policies (Details) - Schedule of Property and Equipment
Jun. 30, 2024
Equipment [Member]  
Schedule of Property and Equipment [Line Items]  
Estimated useful life 5 years
Website and other [Member]  
Schedule of Property and Equipment [Line Items]  
Estimated useful life 3 years
Minimum [Member] | Furniture and fixtures [Member  
Schedule of Property and Equipment [Line Items]  
Estimated useful life 3 years
Maximum [Member] | Furniture and fixtures [Member  
Schedule of Property and Equipment [Line Items]  
Estimated useful life 5 years
v3.24.2.u1
Accrued Expenses (Details) - Schedule of Accrued Expenses - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Accrued Expenses [Abstract]    
Salaries, payroll taxes and vacation $ 170,329 $ 167,930
Merchant card fees 21,500 14,983
Professional fees 101,920 83,532
Management incentives 203,431 503,800
Lease liability 74,116 68,321
Development costs 70,000 109,000
Other 126,421 203,632
Totals $ 767,717 $ 1,151,198
v3.24.2.u1
Stockholders’ Equity and Redeemable Preferred Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Nov. 21, 2023
Jan. 25, 2023
May 31, 2017
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Stockholders’ Equity and Redeemable Preferred Stock [Line Items]              
Voting stock percentage           50.00%  
Voting rights share           one  
January 2023 Offering [Member]              
Stockholders’ Equity and Redeemable Preferred Stock [Line Items]              
Number of shares issued   529,250          
Common stock purchase warrants   10,585,000          
Purchase price (in Dollars per share)   $ 2.52          
Warrants to purchase   3,440,000          
Aggregate shares   258,000          
Price per share (in Dollars per share)   $ 2.52          
Gross proceeds (in Dollars)   $ 5,200,000          
Percentage of underwriting discounts and commissions   7.00%          
Percentage of gross proceeds   3.50%          
Warrant [Member]              
Stockholders’ Equity and Redeemable Preferred Stock [Line Items]              
Purchase of warrants 909,059            
Warrant [Member] | January 2023 Offering [Member]              
Stockholders’ Equity and Redeemable Preferred Stock [Line Items]              
Common stock purchase warrants   61,140          
Additional warrants   815,198          
September 2021 Warrants [Member]              
Stockholders’ Equity and Redeemable Preferred Stock [Line Items]              
Warrant price (in Dollars per share) $ 2            
January 2023 Warrants [Member]              
Stockholders’ Equity and Redeemable Preferred Stock [Line Items]              
Warrant price (in Dollars per share) $ 2            
Series A Warrants [Member]              
Stockholders’ Equity and Redeemable Preferred Stock [Line Items]              
Percentage of common stock issued upon exercise of warrants 200.00%            
Exercise of warrants 80,732            
Warrant exercise price (in Dollars per share) $ 2            
Percentage of immediately exercisable and expire on warrants 50.00%            
Percentage of exercisable warrants 50.00%            
Series B Warrants [Member]              
Stockholders’ Equity and Redeemable Preferred Stock [Line Items]              
Percentage of common stock issued upon exercise of warrants 200.00%            
Exercise of warrants 1,382,058            
Exercise price (in Dollars per share) $ 2            
Percentage of immediately exercisable and expire on warrants 50.00%            
Percentage of exercisable warrants 50.00%            
Prefunded Warrants [Member] | January 2023 Offering [Member]              
Stockholders’ Equity and Redeemable Preferred Stock [Line Items]              
Exercise of warrants   172,000          
Warrant exercise price (in Dollars per share)   $ 0.02          
Common stock purchase warrants   3,440,000          
Series C Redeemable Preferred Stock [Member]              
Stockholders’ Equity and Redeemable Preferred Stock [Line Items]              
Preferred stock dividend rate     15.00%        
Preferred stock dividends (in Dollars)       $ 75 $ 150 $ 75 $ 150
Voting rights share           One  
Common Stock [Member] | January 2023 Offering [Member]              
Stockholders’ Equity and Redeemable Preferred Stock [Line Items]              
Exercisable shares   793,875          
Purchase price (in Dollars per share)   $ 2.52          
v3.24.2.u1
Stockholders’ Equity and Redeemable Preferred Stock (Details) - Schedule of Warrants Outstanding and Exercisable - Warrant [Member]
6 Months Ended
Jun. 30, 2024
USD ($)
$ / shares
shares
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number of Warrants, Outstanding and Exercisable at Beginning | shares 9,531,242
Weighted Average Exercise Price, Outstanding and Exercisable at Beginning | $ / shares $ 39.44
Weighted Average Remaining Life In Years, Outstanding and Exercisable at Beginning | $
Aggregate Intrinsic Value, Outstanding and Exercisable at Beginning 3 years 8 months 19 days
Number of Warrants, Expired warrants | shares (246,952)
Weighted Average Exercise Price, Expired warrants | $ / shares $ 305
Weighted Average Remaining Life In Years, Expired warrants
Aggregate Intrinsic Value, Expired warrants | $
Number of Warrants, Outstanding and Exercisable at ending | shares 9,284,290
Weighted Average Exercise Price, Outstanding and Exercisable at ending | $ / shares $ 33.09
Weighted Average Remaining Life In Years, Outstanding and Exercisable at ending | $
Aggregate Intrinsic Value, Outstanding and Exercisable at ending 3 years 2 months 26 days
v3.24.2.u1
Stock Incentive Plans (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 07, 2023
Aug. 24, 2017
Jan. 04, 2013
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Stock Incentive Plans [Line Items]              
Vested stock options           1,375  
Price per share (in Dollars per share)       $ 1.06   $ 1.06  
Exercise price (in Dollars per share)       $ 1.73   $ 1.73  
Fully vested stock options           42,138  
Stock based compensation expense (in Dollars)       $ 400,000 $ 400,000 $ 800,000 $ 800,000
2023 Stock Incentive Plan [Member]              
Stock Incentive Plans [Line Items]              
Number of shares issued 68,723         322,562  
Common shares outstanding, percentage 15.00%            
Vested stock options       625      
Exercise price (in Dollars per share)       $ 1   $ 1  
Fully vested stock options           40,000  
Aggregate fair value (in Dollars)           $ 85,400  
Unrecognised compensation cost (in Dollars)           $ 26,400  
Stock options forfeited           1,125  
2023 Stock Incentive Plan [Member] | Five Non Employee Board Directors [Member]              
Stock Incentive Plans [Line Items]              
Exercise price (in Dollars per share)       1.06   $ 1.06  
2023 Stock Incentive Plan [Member] | Non-employee Board Directors [Member]              
Stock Incentive Plans [Line Items]              
Exercise price (in Dollars per share)       $ 1   $ 1  
Fully vested stock options           16,854  
2017 Stock Incentive Plan [Member]              
Stock Incentive Plans [Line Items]              
Common shares outstanding, percentage   10.00%          
Vested stock options       10,528   3,125  
Exercise price (in Dollars per share)       $ 3.8   $ 3.8  
Aggregate fair value (in Dollars)             $ 11,000
Stock options forfeited         125 1,000 750
2017 Stock Incentive Plan [Member] | Non-employee Board Directors [Member]              
Stock Incentive Plans [Line Items]              
Exercise price (in Dollars per share)       $ 3.8   $ 3.8  
Aggregate fair value (in Dollars)       $ 35,000      
2017 Stock Incentive Plan [Member]              
Stock Incentive Plans [Line Items]              
Unrecognised compensation cost (in Dollars)           $ 17,900  
Stock options vesting term           4 years  
2013 Long Term Stock Incentive Plan [Member]              
Stock Incentive Plans [Line Items]              
Common shares outstanding, percentage     10.00%        
Unrecognised compensation cost (in Dollars)           $ 200,000  
Stock options forfeited           1,250  
v3.24.2.u1
Commitments and Contingencies (Details) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Commitments and Contingencies [Line Items]          
Lease term       5 years  
Lease agreement amount       $ 300,000  
Monthly rent $ 6,400        
Increasing annual rent, percentage 3.00%        
Operating lease cost   $ 19,200 $ 25,200 38,500 $ 50,700
Louisville, Kentucky [Member]          
Commitments and Contingencies [Line Items]          
Monthly rent       $ 6,600  
v3.24.2.u1
Commitments and Contingencies (Details) - Schedule of Future Minimum Lease Payments
Jun. 30, 2024
USD ($)
Schedule of Future Minimum Lease Payments [Abstract]  
2024 (for the remainder of 2024) $ 40,400
2025 54,400
Total future minimum lease payments 94,800
Less imputed interest (7,302)
Total present value of future minimum lease payments $ 87,498
v3.24.2.u1
Commitments and Contingencies (Details) - Schedule of Lease Expense - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Lease Expense [Abstract]    
Operating lease right-of-use assets $ 82,298 $ 113,761
Accrued expenses 74,116  
Other long-term liabilities 13,382 $ 51,842
Total $ 87,498  
Weighted Average Remaining Lease Term 1 year 2 months 1 day  
Weighted Average Discount Rate 13.00%  
v3.24.2.u1
Subsequent Event (Details) - Subsequent Event [Member] - USD ($)
$ / shares in Units, $ in Millions
Aug. 12, 2024
Aug. 05, 2024
Subsequent Event [Line Items]    
Aggregate units sold   1,449,916
Price per unit (in Dollars per share)   $ 0.4654
Exercisable shares of common stock   1,449,916
Prefunded units.   8,220,084
Gross proceeds (in Dollars)   $ 4.5
Series A Warrants [Member]    
Subsequent Event [Line Items]    
Warrants to purchase common stock   1,449,916
Series B Warrants [Member]    
Subsequent Event [Line Items]    
Warrants to purchase common stock   1,449,916
August Series B Warrants [Member]    
Subsequent Event [Line Items]    
Exercisable shares of common stock   1,449,916
Number of warrants   8,220,084
August Pre-Funded Warrants [Member]    
Subsequent Event [Line Items]    
Exercisable shares of common stock   8,220,084
Aggregate shares of common stock 2,421,930  
August Series A Warrants [Member]    
Subsequent Event [Line Items]    
Number of warrants   8,220,084
Common Stock [Member]    
Subsequent Event [Line Items]    
Shares of common stock   1,449,916
Common stock, par value (in Dollars per share)   $ 0.0001
Common Stock [Member] | August Pre-Funded Warrants [Member]    
Subsequent Event [Line Items]    
Price per unit (in Dollars per share)   0.001
Prefunded Units [Member]    
Subsequent Event [Line Items]    
Offering price (in Dollars per share)   $ 0.4644
Prefunded Common Stock [Member]    
Subsequent Event [Line Items]    
Common stock purchase warrants   8,220,084

LogicMark (NASDAQ:LGMK)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more LogicMark Charts.
LogicMark (NASDAQ:LGMK)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more LogicMark Charts.